[{"text": "70+ Key Companies Advancing in Dry Age-Related Macular Degeneration Clinical Trial Therapeutic Space | DelveInsight PR Newswire Fri, Jan 24, 2025, 1:31 AM 10 min read Dry macular degeneration is a common eye disorder among people aged above 50 years. It causes blurred or reduced central vision due to thinning of the macula. The macula is the part of the retina responsible for clear vision in a direct line of sight. The pharmaceutical industry is increasingly focused on developing pathway-based therapies for dry AMD, with promising treatments like ALK-001 and LBS-008 in trials, though a combination approach may be needed to fully inhibit disease progression. LAS VEGAS , Jan. 23, 2025 /PRNewswire/ -- DelveInsight's ' Dry Age-Related Macular Degeneration Pipeline Insight 2025 ' report provides comprehensive global coverage of pipeline dry AMD therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the dry AMD pipeline domain. DelveInsight Logo Key Takeaways from the Dry Age-Related Macular Degeneration Pipeline Report DelveInsight's dry AMD pipeline report depicts a robust space with 70+ active players working to develop 80+ pipeline therapies for dry AMD treatment. Key dry AMD companies such as Alkeus Pharmaceuticals, Dobecure, Belite Bio, Cognition Therapeutics, Aviceda Therapeutics, Stealth BioTherapeutics, Allergo Ophthalmics, Annexon, Inc., Johnson & Johnson, InflammX Therapeutics, Lineage Cell Therapeutics, Ionis Pharmaceuticals, Evergreen Therapeutics, Inc., Alexion, Luxa Biotechnology, Astellas Pharma, OliX Pharmaceuticals, Hoffmann-La Roche, Boehringer Ingelheim, Eyevensys and others are evaluating new dry AMD drugs to improve the\u00a0treatment landscape. Promising dry AMD pipeline therapies such as ALK-001, Etamsylate, Tinlarebant (LBS-008), CT1812, AVD-104, Elamipretide, Risuteganib, ANX 007, JNJ 81201887, Xiflam, OpRegen, IONIS-FB-LRx, EG-301, ALXN2040, RPESC-RPE-4W, MA09-hRPE, OLX301A, RO7303359, BI 771716, EYS 611 and others are under different phases of dry AMD clinical trials. In December 2024 , Galimedix Therapeutics announced the initiation of its Phase II eDREAM study to assess the safety and efficacy of GAL-101 eye drops in patients with dry age-related macular degeneration. In December 2024 , Ocugen, Inc. announced that the Data and Safety Monitoring Board (DSMB) for the OCU410 ArMaDa clinical trial recently convened and approved continuation of the second phase of the Phase 1/2 study. OCU410 (AAV5-hRORA) is a novel modifier gene therapy candidate being developed for geographic atrophy (GA) secondary to dry age-related macular degeneration (dAMD). In November 2024 , Ocugen, Inc. announced positive preliminary efficacy and safety data from the Phase I dose-escalation portion of the Phase 1/2 OCU410 ArMaDa clinical trial for geographic atrophy (GA), secondary to dry age-related macular degeneration (dAMD). Key findings include: no drug-related serious adverse events, reduced lesion growth, preservation of retinal tissue, and most importantly there was a positive effect on the functional visual measure of low luminance visual acuity (LLVA). In October 2024 , Eyestem Research, focused on creating scalable cell therapies for incurable diseases, had announced a positive outcome of the Drug Safety Monitoring Board (DSMB) review for the first cohort of its Phase one trial to treat Geographic Atrophy secondary to Dry Age-related Macular Degeneration, marking a milestone for Indian science and medical research. In September 2024 , Stealth BioTherapeutics Inc. announced the presentation of new bevemipretide (SBT-272) preclinical data demonstrating topical ocular delivery to the retina with protective effects observed in models of AMD. In June 2024 , Stealth BioTherapeutics Inc. announced that it has enrolled and dosed its first patient in the ReNEW trial as part of its Phase III clinical program for elamipretide in patients with dry age-related macular degeneration (dry AMD). The program consists of the two Phase III trials, ReNEW and ReGAIN. Both trials will evaluate the efficacy, safety, and pharmacokinetics of daily subcutaneous injections of elamipretide in participants with dry AMD. In April 2024 , \u00a0 Eyestem received approval from India's Central Drugs Standards Control Organisation (CDSCO) to commence human trials for Eyecyte RPE, a potential treatment for geographic atrophy arising from dry age-related macular degeneration (AMD). Story Continues Request a sample and discover the recent advances in dry AMD treatment drugs @ Dry Age-Related Macular Degeneration Pipeline Report The dry AMD pipeline report provides detailed profiles of pipeline assets, a comparative analysis of clinical and non-clinical stage dry AMD drugs, inactive and dormant assets, a comprehensive assessment of driving and restraining factors, and an assessment of opportunities and risks in the dry AMD clinical trial landscape. Dry Age-Related Macular Degeneration Overview Age-related macular degeneration (AMD) is one of the top four causes of blindness in older adults and the leading cause of irreversible blindness in developed countries. Around 170 million people globally are affected by AMD, making it the third most common cause of vision loss worldwide. Dry AMD typically progresses slowly, but wet AMD can cause severe visual impairment within days or weeks of onset. In the early stages of AMD, there are no noticeable symptoms, though an ophthalmologist can detect drusen before symptoms arise. Some individuals experience slight vision changes during the intermediate stage, but many remain symptom-free. Others may notice dark or grey spots in their central vision or have difficulty transitioning from bright to dim lighting. Clinicians currently use various imaging techniques to monitor changes in the retina, retinal pigment epithelium (RPE), and choroid, including fundus exams, color fundus photography, fundus autofluorescence (FAF), optical coherence tomography (OCT), and infrared reflectance imaging. Over the past two decades, OCT has significantly advanced the early detection, monitoring, and treatment assessment of dry AMD. Modern spectral-domain OCT (SD-OCT) systems provide detailed cross-sectional and volumetric views of the retina, enabling clinicians to visualize, measure, and monitor retinal layers, RPE, hyperreflective foci, geographic atrophy (GA), and drusen. While SD-OCT remains the standard of care, emerging technologies like polarization-sensitive OCT (PS-OCT), which offers tissue-selective imaging, may revolutionize AMD research and clinical practices. Currently, no approved treatments exist for dry AMD. Management involves regular monitoring, timely detection of visual deterioration, appropriate rehabilitation, and early identification of choroidal neovascularization (CNV). Research is underway to explore therapeutic strategies to prevent AMD, slow its progression, or restore vision. Potential treatments include lifestyle and behavioral changes, age-related eye disease study (AREDS) supplements, visual cycle modulators, anti-inflammatory agents, complement inhibitors, gene therapy, cell-based therapies, and approaches to reduce toxic by-products. Find out more about dry AMD treatment drugs @ Drugs for Dry Age-Related Macular Degeneration Treatment A snapshot of the Dry Age-Related Macular Degeneration Pipeline Drugs mentioned in the report: Drugs Company Phase MoA RoA ALK-001 Alkeus Pharmaceuticals Phase III Dimerisation inhibitors; Vitamin A replacements Oral Tinlarebant (LBS-008) Belite Bio Phase III RBP4 protein inhibitors Oral CT1812 Cognition Therapeutics Phase II Sigma-2 receptor antagonists Oral AVD-104 Aviceda Therapeutics Phase II Complement factor H stimulants; Macrophage inhibitors Intravitreal OCU410 Ocugen Phase I/II Gene transference Subretinal CPCB-RPE1 Regenerative Patch Technologies Phase I/II Cell replacements Subretinal OLX301A OliX Pharmaceuticals Phase I RNA interference NA RO7303359 Hoffmann-La Roche Phase I Undefined mechanism Intravitreal Research program: Dry AMD Beacon Therapeutics Preclinical NA Intravitreal Learn more about the emerging dry AMD pipeline therapies @ Dry Age-Related Macular Degeneration Clinical Trials Dry Age-Related Macular Degeneration Therapeutics Assessment The\u00a0dry AMD pipeline\u00a0report proffers an integral view of the dry AMD emerging novel therapies segmented by stage, product type, molecule type, mechanism of action, and route of administration. Scope of the Dry Age-Related Macular Degeneration Pipeline Report Coverage :\u00a0Global Therapeutic Assessment By Product Type: Mono, Combination, Mono/Combination Therapeutic Assessment By Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III Therapeutics Assessment By Route of Administration: Oral, Intravenous, Subcutaneous, Parenteral, Topical Therapeutics Assessment By Molecule Type : Recombinant fusion proteins, Small molecule, Monoclonal antibody, Peptide, Polymer, Gene therapy Therapeutics Assessment By Mechanism of Action: Dimerisation inhibitors, Vitamin A replacements, RBP4 protein inhibitors, Sigma-2 receptor antagonists, Complement factor H stimulants, Macrophage inhibitors, Cell replacements, RNA interference, Key Dry Age-Related Macular Degeneration Companies : Alkeus Pharmaceuticals, Dobecure, Belite Bio, Cognition Therapeutics, Aviceda Therapeutics, Stealth BioTherapeutics, Allergo Ophthalmics, Annexon, Inc., Johnson & Johnson, InflammX Therapeutics, Lineage Cell Therapeutics, Ionis Pharmaceuticals, Evergreen Therapeutics, Inc., Alexion, Luxa Biotechnology, Astellas Pharma, OliX Pharmaceuticals, Hoffmann-La Roche, Boehringer Ingelheim, Eyevensys and others Key Dry Age-Related Macular Degeneration Pipeline Therapies : ALK-001, Etamsylate, Tinlarebant (LBS-008), CT1812, AVD-104, Elamipretide, Risuteganib, ANX 007, JNJ 81201887, Xiflam, OpRegen, IONIS-FB-LRx, EG-301, ALXN2040, RPESC-RPE-4W, MA09-hRPE, OLX301A, RO7303359, BI 771716, EYS 611 and others. Dive deep into rich insights for new drugs for dry AMD treatment, visit\u00a0@ Dry Age-Related Macular Degeneration Drugs Table of Contents 1. Dry Age-Related Macular Degeneration Pipeline Report Introduction 2. Dry Age-Related Macular Degeneration Pipeline Report Executive Summary 3. Dry Age-Related Macular Degeneration Pipeline: Overview 4. Analytical Perspective In-depth Commercial Assessment 5. Dry Age-Related Macular Degeneration Clinical Trial Therapeutics 6. Dry Age-Related Macular Degeneration Pipeline: Late-Stage Products (Pre-registration) 7. Dry Age-Related Macular Degeneration Pipeline: Late-Stage Products (Phase III) 8. Dry Age-Related Macular Degeneration Pipeline: Mid-Stage Products (Phase II) 9. Dry Age-Related Macular Degeneration Pipeline: Early-Stage Products (Phase I) 10. Dry Age-Related Macular Degeneration Pipeline Therapeutics Assessment 11. Inactive Products in the Dry Age-Related Macular Degeneration Pipeline 12. Company-University Collaborations (Licensing/Partnering) Analysis 13. Key Companies 14. Key Products in the Dry Age-Related Macular Degeneration Pipeline 15. Unmet Needs 16. Market Drivers and Barriers 17. Future Perspectives and Conclusion 18. Analyst Views 19. Appendix For further information on the dry AMD\u00a0pipeline therapeutics, reach out @ Dry Age-Related Macular Degeneration\u00a0Treatment Drugs Related Reports Dry Age-Related Macular Degeneration\u00a0Market Dry Age-Related Macular Degeneration\u00a0Market Insights, Epidemiology, and Market Forecast \u2013 2034 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, market share of the individual therapies, and key dry AMD\u00a0companies including Alkeus Pharmaceuticals, Belite Bio, Aviceda Therapeutics, Johnson & Johnson Innovative Medicine, Allegro Ophthalmics, Lineage Cell Therapeutics (CellCure Neurosciences), Roche, Cognition Therapeutics, Stealth BioTherapeutics, Evergreen Therapeutics, Annexon Biosciences, NGM Biopharmaceuticals, AstraZeneca, Alexion Pharmaceuticals, Ionis Pharmaceuticals, Novartis, Regenerative Patch Technologies, among others. Dry Age-related Macular Degeneration Epidemiology Forecast Dry Age-related Macular Degeneration Epidemiology Forecast \u2013 2034 report delivers an in-depth understanding of the disease, historical and forecasted dry AMD epidemiology in the 7MM, i.e., the United States , EU4 ( Germany , France , Italy , and Spain ), the United Kingdom , and Japan . Age-related Macular Degeneration\u00a0Market Age-related Macular Degeneration\u00a0Market Insights, Epidemiology, and Market Forecast \u2013 2034 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, market share of the individual therapies, and key AMD\u00a0companies including Regeneron Pharmaceuticals, Novartis, Roche, Opthea Limited, Kodiak Sciences Inc., REGENXBIO, Alkahest Inc, Graybug Vision, Ribomic USA Inc, Outlook Therapeutics, Inc., Unity Biotechnology, Inc, PanOptica, Inc., Clearside Biomedical, Alexion Pharmaceuticals, AstraZeneca, Evergreen Therapeutics, Alkeus Pharmaceuticals, Stealth BioTherapeutics, CellCure Neurosciences, Regenerative Patch Technologies, Allegro Ophthalmics, Annexon Biosciences, NGM Biopharmaceuticals, Ionis Pharmaceuticals, Apellis Pharmaceuticals, Iveric Bio, Gyroscope Therapeutics, Luxa Biotechnology, Gemini Therapeutics , among others. Wet Age-related Macular Degeneration Market Wet Age-related Macular Degeneration Market Insights, Epidemiology, and Market Forecast \u2013 2034 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key Wet Age-related Macular Degeneration companies including EyePoint Pharmaceuticals, Inc., AbbVie, Caregen Co. Ltd., Exegenesis Bio, Shanghai Henlius Biotech, Skyline Therapeutics, 4D Molecular Therapeutics, Ocugenix Corporation, Adverum Biotechnologies, Inc., Ashvattha Therapeutics, Inc., AiViva BioPharma, Inc., Ocular Therapeutix, Inc., Clearside Biomedical, Inc., Hoffmann-La Roche, Kyowa Kirin, Inc., Opthea Limited, AffaMed Therapeutics Limited, EyeBiotech Ltd., Novartis , among others. About\u00a0DelveInsight DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.\u00a0Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform\u00a0PharmDelve . Contact Us Shruti Thakur info@delveinsight.com +14699457679 www.delveinsight.com Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg Cision View original content: https://www.prnewswire.com/news-releases/70-key-companies-advancing-in-dry-age-related-macular-degeneration-clinical-trial-therapeutic-space--delveinsight-302358146.html SOURCE DelveInsight Business Research, LLP View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "AVD", "date": "2025-01-23T22:31:00+00:00", "sentiment": {"score": 0.1911925571039319, "confidence": 0.20089158415794373, "probabilities": {"positive": 0.20089158415794373, "negative": 0.009699027054011822, "neutral": 0.7894094586372375}}, "embedding": [-0.0758654922246933, -0.16440977156162262, 0.09496226906776428, -0.0882750153541565, 0.023636439815163612, -0.17404960095882416, -0.12276778370141983, 0.16050174832344055, -0.023108389228582382, 0.09584672003984451, -0.05250239744782448, -0.020968886092305183, 0.06859982758760452, 0.030348122119903564, -0.08533581346273422, 0.1969497799873352, -0.02881937474012375, 0.06476795673370361, -0.06552404910326004, 0.04439210146665573, 0.24880243837833405, 0.02176985703408718, -0.0037032095715403557, 0.0829533115029335, -0.05554812029004097, 0.03826115280389786, 0.15371571481227875, -0.061078667640686035, -0.1260625272989273, -0.17573294043540955, 0.0727662742137909, 0.1366778016090393, -0.006982844788581133, -0.09859330952167511, 0.04917220026254654, 0.05085548013448715, -0.0798291489481926, -0.08098992705345154, -0.23768389225006104, -0.05235898494720459, -0.05190061032772064, -0.004957369063049555, -0.09525579959154129, 0.008882042951881886, 0.15569670498371124, -0.20862796902656555, -0.08300977945327759, 0.045301832258701324, 0.027294838801026344, 0.19192802906036377, -0.17129258811473846, -0.0830618143081665, -0.038570720702409744, 0.1052398607134819, -0.03429529443383217, 0.056152015924453735, -0.26956719160079956, -0.06513207405805588, 0.12047776579856873, 0.022952619940042496, 0.092007577419281, -0.1427188664674759, 0.09016687422990799, -0.06508204340934753, -0.060453496873378754, 0.031792305409908295, -0.03272642567753792, -0.116462841629982, 0.0024522054009139538, -0.12240245938301086, -0.05257384479045868, -0.059912580996751785, 0.10408561676740646, 0.07599368691444397, -0.04847823455929756, 0.13154013454914093, 0.1815146505832672, -0.07397991418838501, 0.09571491181850433, -0.0934506505727768, 0.16098780930042267, 0.08856995403766632, 0.18919220566749573, -0.01604536548256874, 0.14393837749958038, 0.060243669897317886, -0.03365694731473923, 0.13356944918632507, 0.08057734370231628, 0.05941160023212433, 0.03203541412949562, 0.09613558650016785, -0.10505397617816925, 0.055376630276441574, 0.035270221531391144, -0.12163575738668442, 0.033283598721027374, 0.06340312957763672, -0.033817291259765625, 0.03525128960609436, -0.08001662790775299, 0.021657872945070267, 0.06170126050710678, -0.0757361501455307, -0.09410630166530609, -0.08620043098926544, 0.17754656076431274, 0.03417686000466347, -0.017150213941931725, -0.005899908021092415, -0.008779702708125114, -0.016226861625909805, 0.04427611082792282, 0.08401551842689514, 0.007052214350551367, 0.12530891597270966, -0.0749296173453331, -0.014561140909790993, 0.20370319485664368, -0.05874526500701904, 0.04529185593128204, 0.04905455559492111, 0.047257520258426666, 0.0028747571632266045, 0.07178933173418045, 0.11363603919744492, -0.022303132340312004, 1.5239884590331678e-32, -0.07044953107833862, -0.023140832781791687, -0.1390150487422943, 0.07776788622140884, 0.051826611161231995, -0.1274002492427826, 0.0651894211769104, 0.02395518682897091, -0.29542848467826843, -0.21007922291755676, -0.23986101150512695, 0.03842228651046753, -0.0038490304723381996, 0.2519671320915222, -0.040436189621686935, -0.2449450045824051, 0.12349846959114075, 0.1303824633359909, -0.04031848907470703, -0.11554664373397827, -0.04724067449569702, 0.10623101145029068, -0.14069654047489166, 0.04152419790625572, 0.0008145170286297798, 0.060194242745637894, 0.005313466303050518, 0.10032474994659424, 0.02610964886844158, 0.01836537942290306, -0.07434951514005661, 0.05715333670377731, 0.0195816271007061, -0.17095181345939636, -0.108502596616745, 0.030324649065732956, -0.05397995933890343, -0.07796302437782288, -0.05374756082892418, 0.045777276158332825, -0.09990397095680237, 0.23057323694229126, -0.10485075414180756, -0.10805882513523102, 0.028757642954587936, -0.09611481428146362, -0.10702715814113617, 0.1113201230764389, -0.09049320966005325, -0.011047644540667534, -0.020715421065688133, -0.01311306282877922, -0.0610140897333622, -0.16539114713668823, -0.10451973974704742, 0.0495089516043663, -0.18608158826828003, 0.013039826415479183, 0.15582139790058136, 0.1200583353638649, -0.03441515192389488, 0.11379949003458023, -0.018095126375555992, 0.15679465234279633, 0.03162087872624397, 0.06209071725606918, 0.07079505920410156, 0.03418082743883133, -0.10883596539497375, 0.022772736847400665, 0.0026764110662043095, -0.006937811151146889, 0.20045539736747742, -0.003466593101620674, 0.17020800709724426, -0.007062969729304314, 0.09235700219869614, 0.06734798848628998, -0.07799828052520752, -0.07762461155653, 0.03349396213889122, 0.1367778778076172, -0.12747111916542053, 0.09354805946350098, 0.06907898932695389, 0.028315190225839615, -0.0409117229282856, 0.07176533341407776, -0.13303227722644806, -0.014297863468527794, 0.11881428956985474, -0.09553982317447662, -0.013586677610874176, 0.05146734416484833, 0.01644296571612358, -1.2722667763169385e-32, 0.023143284022808075, -0.0391734316945076, -0.038036048412323, 0.04765787348151207, -0.11148031055927277, 0.26048514246940613, 0.15712499618530273, -0.09043765068054199, 0.14841091632843018, -0.3714691698551178, 0.08485770225524902, 0.08627238869667053, -0.11110597103834152, -0.14013837277889252, -0.10140235722064972, 0.04841624200344086, -0.08638612180948257, -0.05784723907709122, -0.17873889207839966, -0.017279671505093575, 0.10601024329662323, 0.25203073024749756, -0.05970317870378494, 0.01090654544532299, -0.00032534520141780376, 0.07410552352666855, 0.08245281875133514, -0.010074907913804054, -0.03713538870215416, 0.1455514132976532, -0.15026742219924927, 0.11752630025148392, -0.2592621147632599, -0.04526502639055252, -0.0717168003320694, 0.04412193223834038, -0.0866197720170021, -0.16123437881469727, -0.10837165266275406, -0.05887136235833168, 0.05820823460817337, 0.01557187084108591, 0.007643629796802998, -0.1144808977842331, -0.024309199303388596, 0.1106339767575264, 0.08460494875907898, -0.10134042799472809, 0.1400964856147766, -0.005724914371967316, -0.12000332772731781, 0.018795911222696304, 0.010125210508704185, 0.04524271935224533, -0.09135046601295471, -0.02525937929749489, 0.058963436633348465, -0.03398417681455612, -0.09169233590364456, 0.008177396841347218, -0.004467400722205639, -0.0070794979110360146, 0.16667768359184265, -0.15219689905643463, 0.1318521350622177, 0.1408570557832718, 0.10245910286903381, 0.1017911359667778, 0.038549311459064484, -0.12852641940116882, 0.08169413357973099, -0.08828839659690857, -0.11264914274215698, 0.03562133386731148, 0.12909018993377686, 0.0031574945896863937, 0.006854016799479723, 0.060803428292274475, -0.23877501487731934, 0.1387888789176941, 0.0906987190246582, -0.037019211798906326, -0.05139193683862686, 0.13312074542045593, 0.09405694901943207, 0.06051114946603775, 0.0774100124835968, -0.08176020532846451, 0.03991920128464699, 0.10547180473804474, -0.13421599566936493, -0.17809244990348816, -0.14104719460010529, 0.07046768814325333, -0.10126538574695587, -1.0000923822417462e-07, 0.05116698145866394, 0.03464791923761368, 0.08853598684072495, -0.13077446818351746, 0.009024913422763348, -0.09769800305366516, -0.0976242870092392, 0.2932843863964081, -0.06397365033626556, -0.0648343414068222, 0.021382588893175125, 0.18692317605018616, -0.08165609836578369, 0.07754967361688614, 0.02444642223417759, 0.07916319370269775, -0.009333496913313866, 0.08691982924938202, -0.06227279454469681, -0.1407279074192047, -0.15548966825008392, -0.021531617268919945, 0.06063328683376312, 0.06047787517309189, 0.039861492812633514, 0.0020324252545833588, 0.03169350326061249, 0.08611418306827545, 0.08929666876792908, -0.0379079207777977, 0.06762465834617615, 0.026760727167129517, 0.15632635354995728, 0.024128492921590805, 0.014088419266045094, -0.11454148590564728, -0.021267378702759743, 0.22104167938232422, -0.03579846769571304, 0.21647725999355316, -0.12203999608755112, -0.013166485354304314, 0.07570219039916992, -0.028951648622751236, -0.09260663390159607, -0.021362243220210075, 0.029084544628858566, 0.00772355031222105, -0.13772323727607727, -0.01966269686818123, -0.06728443503379822, -0.01608806848526001, -0.007239443250000477, -0.027907077223062515, -0.18974697589874268, 0.041807983070611954, 0.04572191834449768, -0.05384453758597374, -0.018712081015110016, -0.10607337951660156, 0.06933671981096268, -0.1275683343410492, 0.1258191168308258, -0.011945165693759918], "changes": {"1wk": 8.556149868980281}}, {"text": "American Vanguard CEO Dak Kaye to be Featured in Lake Street Capital Investor Forum Business Wire Thu, Jan 9, 2025, 5:00 PM 2 min read In This Article: AVD -1.62% NEWPORT BEACH, Calif., January 09, 2025 --( BUSINESS WIRE )--American Vanguard Corporation (NYSE:AVD) has announced that CEO, Douglas \"Dak\" Kaye, III, will be participating in an investor forum with Lake Street Capital analyst Ben Klieve on January 16, 2025 at 11 a.m. Eastern Time. This forum will be Mr. Kaye\u2019s first presentation to the financial community as the CEO of American Vanguard. Mr. Kaye brings more than 20 years of executive leadership experience to American Vanguard, most recently serving as North American President of Albaugh, LLC, a global developer, manufacturer, and marketer of crop protection products. Please contact Lake Street Capital Markets if interested in participating in this forum. About American Vanguard Corporation American Vanguard Corporation (AVD) is a diversified specialty and agriculture products company that develops and markets products for crop protection and management, turf and ornamentals management, and public and animal health. Over the past 20 years, through product and business acquisitions, the Company has expanded its operations into 21 countries and now has more than 1,000 product registrations in 56 nations, worldwide. To learn more about the Company, please reference www.american-vanguard.com . Forward Looking Statements The Company, from time to time, may discuss forward-looking information. Except for the historical information contained in this release, all forward-looking statements are estimates by the Company\u2019s management and are subject to various risks and uncertainties that may cause results to differ from management\u2019s current expectations. Such factors include weather conditions, changes in regulatory policy and other risks as detailed from time-to-time in the Company\u2019s SEC reports and filings. All forward-looking statements, if any, in this release represent the Company\u2019s judgment as of the date of this release. View source version on businesswire.com: https://www.businesswire.com/news/home/20250109794592/en/ Contacts Company Contact American Vanguard Corporation Anthony Young, Director of Investor Relations anthonyy@amvac.com (949) 221-6119 Investor Representative Alpha IR Group Robert Winters Robert.winters@alpha-ir.com (929) 266-6315 View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "AVD", "date": "2025-01-09T14:00:00+00:00", "sentiment": {"score": 0.002637576311826706, "confidence": 0.026242569088935852, "probabilities": {"positive": 0.026242569088935852, "negative": 0.023604992777109146, "neutral": 0.9501524567604065}}, "embedding": [-0.03940064087510109, -0.05223209038376808, -0.0034169116988778114, -0.022340714931488037, 0.19481009244918823, -0.04902420938014984, -0.021368127316236496, 0.0320979580283165, 0.10773664712905884, 0.05755232274532318, -0.032782696187496185, 0.09496299177408218, -0.04451988637447357, -0.06182241812348366, -0.10949380695819855, -0.07677124440670013, 0.0006913156248629093, -0.0359773114323616, -0.11160775274038315, 0.017900066450238228, -0.07546660304069519, 0.003006305079907179, 0.01311014499515295, 0.09850957989692688, 0.013900747522711754, -0.012396194040775299, -0.07563378661870956, -0.012827226892113686, -0.2081184685230255, -0.10196816176176071, -0.067814901471138, -0.01728932559490204, 0.03389662876725197, 0.044125016778707504, 0.009447706863284111, 0.09644384682178497, 0.009731955826282501, 0.024069584906101227, -0.09186631441116333, -0.1162663996219635, 0.04850149154663086, -0.16994798183441162, -0.04306242614984512, -0.009764996357262135, 0.02663794904947281, 0.09029635787010193, -0.07955669611692429, 0.056848954409360886, 0.02520761825144291, 0.04365771263837814, -0.02757033333182335, -0.06024130433797836, 0.05840626731514931, -0.05714378505945206, -0.04634785279631615, 0.15572649240493774, -0.1052868664264679, -0.009177614003419876, 0.04793493449687958, -0.06268822401762009, 0.06816014647483826, -0.10510504245758057, 0.008601765148341656, 0.09145104885101318, 0.05692538619041443, -0.0009115282446146011, -0.027605928480625153, -0.018574299290776253, -0.06061997264623642, -0.12294624000787735, 0.10362501442432404, -0.08128809928894043, -0.08425308018922806, 0.09777577966451645, -0.04767582193017006, 0.17459309101104736, 0.15433044731616974, 0.12123646587133408, 0.12332011759281158, -0.09645833820104599, 0.13413037359714508, 0.19520044326782227, 0.09315349161624908, 0.009396618232131004, -0.08989459276199341, -0.0007411707192659378, 0.10219123214483261, -0.005803669802844524, 0.12559886276721954, -0.028124893084168434, 0.031365763396024704, -0.14120402932167053, -0.04683513194322586, 0.006974264979362488, 0.015809625387191772, 0.027680031955242157, -0.04888032749295235, -0.008588576689362526, -0.12938693165779114, 0.052100054919719696, 0.008995265699923038, 0.040270641446113586, -0.044285550713539124, -0.0767974853515625, -0.1240932047367096, -0.036136552691459656, 0.04371413588523865, -0.013625316321849823, 0.04974513500928879, 0.09147489070892334, -0.029086731374263763, 0.1027383878827095, -0.10377345234155655, -0.08001121878623962, 0.004404689650982618, -0.04764983803033829, -0.10098197311162949, -0.08947819471359253, 0.12706801295280457, -0.12138189375400543, 0.06909509748220444, 0.1359676569700241, 0.0402141734957695, 0.046467557549476624, -0.04949997365474701, 0.02831246331334114, -0.010621985420584679, 6.693289078153091e-33, -0.0358700267970562, 0.06082554906606674, 0.05202522873878479, -0.004269306547939777, -0.021079450845718384, 0.009059654548764229, 0.10280117392539978, 0.007788532413542271, -0.03179516643285751, -0.0008702632039785385, -0.10181465744972229, 0.05581317096948624, -0.020105333998799324, 0.06732175499200821, 0.006704551633447409, 0.00693941954523325, 0.11967316269874573, 0.11023859679698944, 0.10583628714084625, -0.11908306181430817, 0.0041391197592020035, -0.09379014372825623, -0.09918979555368423, 0.03816545009613037, 0.172551691532135, -0.12843412160873413, -0.10404116660356522, 0.01021516416221857, -0.020567046478390694, 0.07040492445230484, 0.0027122758328914642, 0.06395041197538376, 0.017088480293750763, -0.0333288200199604, -0.011682786047458649, 0.04629875719547272, -0.12039491534233093, -0.08047886937856674, 0.03712999075651169, 0.05219973623752594, -0.06377357244491577, 0.12361526489257812, -0.04839475825428963, 0.07731727510690689, -0.036704689264297485, -0.0435107946395874, 0.08554880321025848, 0.13324902951717377, -0.0009964145720005035, 0.014585417695343494, -0.053304195404052734, 0.07065805792808533, 0.0011595692485570908, -0.09082010388374329, 0.11042657494544983, 0.07235606759786606, -0.004157553426921368, -0.04697555676102638, -0.03477322682738304, 0.012278471142053604, 0.01370419841259718, 0.21698006987571716, -0.169258713722229, -0.0038651227951049805, -0.1821780502796173, 0.06010344624519348, 0.09313192963600159, 0.10293719172477722, -0.06391134113073349, 0.0749492272734642, 0.0056926533579826355, -0.057736270129680634, 0.11598701775074005, -0.01092112623155117, 0.002454260364174843, -0.09164340049028397, 0.06832381337881088, 0.12974809110164642, 0.1004931628704071, -0.018484683707356453, -0.04649294912815094, 0.03192746639251709, -0.015438812784850597, 0.03152709826827049, -0.14608365297317505, 0.012808392755687237, 0.09896227717399597, -0.008462276309728622, 0.008374218828976154, 0.030255816876888275, 0.01870649680495262, 0.04444016516208649, 0.05086802691221237, 0.1707485318183899, -0.07715727388858795, -7.364404516976459e-33, -0.05343932658433914, -0.088994100689888, -0.01697682775557041, -0.01762700453400612, 0.014505869708955288, -0.019572898745536804, 0.061342157423496246, 0.07846434414386749, 0.04614179581403732, -0.23983678221702576, 0.005808211863040924, 0.013077309355139732, -0.07198284566402435, 0.052259497344493866, -0.00509325647726655, 0.009038848802447319, 0.005921369418501854, -0.02146921493113041, 0.1354362666606903, -0.0489567331969738, 0.03346977382898331, 0.17139968276023865, -0.05392016842961311, -0.014986664056777954, 0.012106098234653473, -0.037268269807100296, 0.036195315420627594, 0.1661350429058075, -0.061982184648513794, -0.10838271677494049, 0.04450872167944908, -0.002447144128382206, -0.041115812957286835, 0.21482624113559723, -0.16478869318962097, 0.04213913157582283, 0.004315478727221489, -0.11256804317235947, 0.008747739717364311, 0.02162250690162182, 0.06035960838198662, -0.042069919407367706, 0.04265976697206497, -0.05751342326402664, -0.08377756923437119, 0.011983208358287811, 0.09985082596540451, -0.026691751554608345, 0.06895200908184052, -0.032465603202581406, -0.04488159716129303, -0.014455650001764297, -0.0031465538777410984, 0.10871222615242004, -0.16062656044960022, 0.09716876596212387, 0.03682040423154831, 0.07009270042181015, -0.10562151670455933, 0.00945320539176464, 0.04755577817559242, 0.17081789672374725, 0.07904467731714249, 0.10711264610290527, 0.10501281917095184, -0.02280755527317524, 0.008709478192031384, -0.04545043408870697, -0.0437438040971756, -0.06272523105144501, -0.0016808020882308483, -0.12797711789608002, -0.020354755222797394, -0.12409227341413498, 0.030547551810741425, -0.003928639460355043, 0.02792230434715748, -0.12125347554683685, -0.06326661258935928, -0.03721708059310913, -0.023321785032749176, 0.07409891486167908, -0.05439961701631546, 0.15505297482013702, -0.011246439069509506, 0.15413610637187958, -0.020876387134194374, -0.11827677488327026, -0.06646931171417236, 0.13657042384147644, -0.12287859618663788, -0.11597461253404617, -0.1610962301492691, 0.09551996737718582, 0.04779227823019028, -9.907748221849033e-08, 0.12130415439605713, 0.06775146722793579, -0.01320265606045723, -0.004139358177781105, 0.12783585488796234, -0.11159937083721161, 0.07284213602542877, -0.08587021380662918, -0.028605788946151733, 0.032697223126888275, -0.05483130365610123, 0.06702986359596252, -0.13798081874847412, -0.06355592608451843, -0.04847124591469765, -0.1340382844209671, -0.07379079610109329, 0.06857019662857056, -0.12573425471782684, 0.00466805137693882, -0.00025283172726631165, 0.14910945296287537, 0.01142540667206049, -0.14769817888736725, 0.006111692637205124, 0.008268255740404129, 0.08748482167720795, -0.01184157095849514, 0.046618442982435226, 0.11972178518772125, -0.0873551219701767, 0.026315607130527496, -0.0011884039267897606, -0.027231931686401367, 0.019953370094299316, -0.08325851708650589, -0.12635767459869385, 0.022118929773569107, -0.0029392847791314125, 0.11816161870956421, -0.014439916238188744, 0.10316181927919388, 0.07075025141239166, 0.01737145334482193, -0.039571017026901245, -0.057912491261959076, -0.09507167339324951, -0.05840911343693733, 0.01941586285829544, -0.01696164160966873, 0.023145359009504318, -0.06309626251459122, 0.07881557941436768, 0.09286584705114365, -0.013726229779422283, -0.0404726043343544, -0.008106266148388386, -0.13941189646720886, -0.03088868409395218, -0.010532672517001629, -0.00023662298917770386, -0.2914126515388489, 0.04923523962497711, 0.16371747851371765], "changes": {"1wk": 7.675436601414219}}, {"text": "Jeito Capital announces significant participation in upsized $207.5 million Series C financing in Aviceda Therapeutics to advance Lead Program AVD-104 for Geographic Atrophy into Pivotal Trials Jeito Capital Tue, Jan 7, 2025, 3:09 PM 4 min read Jeito Capital Jeito Capital announces significant participation in upsized $207.5 million Series C financing in Aviceda Therapeutics to advance Lead Program AVD-104 for Geographic Atrophy into Pivotal Trials Investment will support the ongoing Phase 2b/3 and planned pivotal Phase 3 clinical trial for AVD-104 in geographic atrophy secondary to age-related macular degeneration (AMD); Aviceda\u2019s ongoing Phase 2b/3 trial evaluating AVD-104 is fully enrolled, with 12-month primary endpoint data anticipated in the second half of 2025. Upsized financing round led by a syndicate of top institutional investors, including Jeito Capital, only European fund within the syndicate, bringing strategic expertise to accelerate Aviceda\u2019s development across US and European markets. Investment demonstrates Jeito's continued strategic focus in ophthalmology, following recent exit of EyeBio to Merck & Co. Paris, France, January 7 th , 2025 \u2013 Jeito Capital (\u201cJeito\u201d), a global leading independent Private Equity fund dedicated to biopharma, announced today its significant participation in the upsized $207.5 million (\u20ac198 million 1 ) Series C financing round in Aviceda Therapeutics (\u201cAviceda\u201d), a private, clinical stage biotech company focused on developing next-generation immunomodulators with a clinical-stage ophthalmic candidate, AVD-104, for the treatment of geographic atrophy (GA), a vision-threatening condition secondary to advanced age-related macular degeneration (AMD). The financing round was co-led by renowned healthcare funds, Omega Funds and TCGX, with significant participation from Jeito Capital and Enavate Sciences, alongside leading investment firms Blue Owl Healthcare Opportunities, Longitude Capital, OrbiMed, Logos Capital, Marshall Wace, Catalio Capital Management, funds managed by abrdn Inc., and Digitalis Ventures. The proceeds will support the ongoing Phase 2b/3 and planned pivotal Phase 3 clinical trial for AVD-104, its late-clinical stage Lead Program in geographic atrophy (GA) and the expansion into additional ophthalmic indications. AVD-104\u2019s dual mechanism of action targets immune modulation and complement inhibition and has already shown positive proof-of-concept efficacy in slowing GA lesion growth and preserving/enhancing visual function in a Phase 2a trial completed in early 2024, which underscores its potential for first-in-class efficacy and safety. Aviceda\u2019s ongoing Phase 2b/3 trial evaluating two doses of AVD-104 versus avacincaptad pegol (Izervay) in patients with GA\u00a0 is fully enrolled, with 12-month primary endpoint data anticipated in the second half of 2025. Story Continues Rafa\u00e8le Tordjman, M.D., PhD and Sara Nayeem, M.D. of Enavate Sciences will join Aviceda\u2019s Board of Director as Board Observers. This investment builds on Jeito\u2019s expertise in ophthalmology, following its recent exit of EyeBio, which was acquired by Merck & Co for up to $3 billion. Jeito\u2019s selection as the only European fund in the syndicate reflects its strategic value in supporting Aviceda\u2019s development goals across both US and European markets. The fund\u2019s global presence and deep understanding of the European healthcare landscape were key factors in management\u2019s decision to include Jeito in this financing round. Dr Rafa\u00e8le Tordjman, MD, PhD, Founder and CEO of Jeito Capital said : \u201c Our investment in Aviceda Therapeutics perfectly illustrates our ambition to champion promising late-clinical stage biopharma with the potential to become global market leaders that will make a meaningful difference in patient lives. We have been impressed by Aviceda\u2019s new mechanism whose first positive results represent a new hope for patients. We look forward to starting this new collaboration and bringing our European expertise and global approach to accelerate this transformative therapy for patients with high unmet needs. \u201d David Guyer, MD, Board Chair of Aviceda added: \u201c W e are pleased to welcome our new board members and a syndicate of top institutional investors. This raise reflects the strong conviction from investors in Aviceda\u2019s lead program AVD-104 for geographic atrophy \u2013 a market poised for disruption and an improved standard of care, given current treatments offer limited benefits in visual improvements, lesion control, and safety. With this upsized financing, the company is well-capitalized to advance a pivotal program for AVD-104 in GA. \u201d About Jeito Capital Jeito Capital is a global leading Private Equity fund with a patient benefit driven approach that finances and accelerates the development and growth of ground-breaking medical innovation. Jeito empowers and supports managers through its expert, integrated, multi-talented team and through the investment of significant capital to ensure the growth of companies, building market leaders in their respective therapeutic areas with accelerated patients\u2019 access globally, especially in Europe and the United States. Jeito Capital has \u20ac534 million under management and a rapidly growing portfolio of investments. Jeito Capital is based in Paris with a presence in Europe and the United States. For more information, please visit www.jeito.life or follow us on LinkedIn or X . About Aviceda Therapeutics and AVD-104 Aviceda is a private, clinical stage biotechnology company located in Cambridge, MA, with a proprietary High Affinity Ligands of Siglecs (HALOS\u2122) nanotechnology platform and a clinical-stage ophthalmic candidate, AVD-104, for the treatment of geographic atrophy secondary to age-related macular degeneration. AVD-104 is an intravitreal glycan-coated nanoparticle with a dual mechanism of action that modulates critical inflammatory cellular and complement pathways through 1) direct deactivation of inflammatory microglia/macrophages\u2019 phagocytic activity and repolarization of these activated microglia/macrophages to their healing state and 2) inhibition of complement cascade amplification. Along with AVD-104, Aviceda has a broad pipeline of products in development in ophthalmology and multiple other therapeutic areas, including immunology, fibrosis, oncology, and neurology. Learn more about Aviceda Therapeutics and follow the company on LinkedIn . Contacts: Jeito Capital Rafa\u00e8le Tordjman, Founder & CEO Jessica Fadel, EA Tel: +33 6 33 44 25 47 Maior St\u00e9phanie Elbaz \u2013 Tel: +33 6 46 05 08 07 ICR Healthcare Mary-Jane Elliott / Davide Salvi / Kris Lam Jeito@icrhealthcare.com Tel: +44 (0) 20 3709 5700 1 EUR/USD exchange rate: 1 EUR = 1.0498 USD date December 16, 2024 (source: Banque de France) View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "AVD", "date": "2025-01-07T12:09:00+00:00", "sentiment": {"score": 0.3864114135503769, "confidence": 0.39445605874061584, "probabilities": {"positive": 0.39445605874061584, "negative": 0.008044645190238953, "neutral": 0.5974993109703064}}, "embedding": [0.061361201107501984, -0.13307732343673706, -0.04765518009662628, -0.0629982128739357, -0.014685912057757378, -0.016999855637550354, -0.08098480105400085, 0.1116674542427063, 0.1554267704486847, 0.20592424273490906, -0.06272117793560028, -0.0012364760041236877, -0.07153713703155518, -0.015825023874640465, -0.06016188859939575, -0.08396241068840027, -0.00034376606345176697, -0.029668660834431648, -0.1100027859210968, 0.11799310147762299, 0.059416163712739944, -0.04432724416255951, 0.08340336382389069, -0.03589637577533722, 0.045007623732089996, 0.004032817203551531, -0.004193297121673822, -0.004357299767434597, -0.17541547119617462, -0.03875244781374931, 0.06377001851797104, 0.06677324324846268, 0.0016240710392594337, -0.09670005738735199, 0.053663551807403564, -0.06856442242860794, -0.20318733155727386, 0.08904354274272919, -0.1970752328634262, -0.002053428441286087, -0.08637486398220062, -0.00198384840041399, -0.19521403312683105, 0.021854467689990997, 0.12245647609233856, -0.19079403579235077, -0.0986628532409668, 0.05677793174982071, 0.03537455573678017, 0.039491068571805954, -0.25396648049354553, -0.20818305015563965, 0.001301672775298357, 0.03109925054013729, -0.14586162567138672, 0.11940066516399384, -0.14653319120407104, -0.04262660816311836, 0.07961159944534302, 0.0395006462931633, 0.01428217999637127, -0.05157692730426788, 0.014083322137594223, -0.07091818004846573, 0.029785657301545143, -0.08876854181289673, 0.12177768349647522, -0.031599804759025574, -0.1318935602903366, -0.09734362363815308, 0.1807759404182434, -0.16612735390663147, 0.060394544154405594, 0.08734435588121414, -0.027300681918859482, 0.20034503936767578, 0.05555213987827301, 0.09425856173038483, 0.24332919716835022, -0.13075876235961914, 0.14663545787334442, 0.03317379578948021, 0.17571285367012024, 0.006869662553071976, -0.0006797816604375839, 0.003841730300337076, 0.013384724967181683, 0.1567232757806778, 0.1074257493019104, 0.09191018342971802, 0.02319139428436756, -0.054069727659225464, 0.0026618046686053276, -0.0018680400680750608, 0.06028168648481369, 0.07321576774120331, -0.200102761387825, -0.03708004951477051, 0.04133300483226776, 0.030692629516124725, 0.017436131834983826, -0.02868259884417057, 0.10611280798912048, -0.08163943141698837, -0.021447425708174706, -0.0067327190190553665, 0.10715056955814362, -0.08258525282144547, 0.15114566683769226, 0.033758677542209625, -0.07459650933742523, 0.070548877120018, -0.012514939531683922, 0.008216219022870064, -0.06723387539386749, 0.3248012065887451, -0.08151979744434357, -0.03250212222337723, 0.35110151767730713, -0.1108098030090332, 0.21185271441936493, -0.0009640548378229141, 0.12243182957172394, -0.09058700501918793, 0.08287601172924042, 0.03185749426484108, -0.27623873949050903, 1.1097214011319496e-32, -0.08222071826457977, -0.03327549993991852, -0.02436039224267006, 0.08130922168493271, -0.12309348583221436, -0.02606227807700634, 0.06614498049020767, 0.07072997093200684, -0.3102230429649353, -0.1188981682062149, -0.20609349012374878, -0.04064635932445526, -0.017911164090037346, 0.1768270879983902, -0.11439108848571777, -0.10906995832920074, 0.02476055547595024, 0.14395835995674133, -0.028995946049690247, -0.05961848050355911, 0.046576112508773804, 0.03502623736858368, 0.01222221553325653, 0.10475903749465942, 0.01288218516856432, 0.03780069947242737, -0.1813497096300125, 0.00835521798580885, 0.0800643116235733, 0.0793842002749443, 0.05263736844062805, 0.12396526336669922, -0.04840990528464317, -0.12752199172973633, -0.10203992575407028, -0.04209936410188675, -0.07745498418807983, -0.06807593256235123, 0.034098781645298004, 0.14398282766342163, 0.007508468348532915, 0.13391996920108795, -0.09859457612037659, -0.07523149251937866, -0.016239572316408157, -0.0826016291975975, -0.06338007748126984, 0.0294240340590477, 0.017184777185320854, 0.0858069658279419, -0.06702183932065964, -0.0785958543419838, -0.03162402659654617, -0.07481559365987778, -0.009849350899457932, 0.1975007951259613, -0.16683083772659302, 0.06693170964717865, -0.005154079757630825, -0.002593373181298375, 0.015336818061769009, 0.1039847880601883, -0.10474924743175507, 0.216794952750206, -0.18521013855934143, 0.07250325381755829, 0.06624005734920502, 0.020546261221170425, -0.16446448862552643, 0.08603925257921219, -0.03437895327806473, -0.09248536825180054, 0.15394555032253265, 0.0327591747045517, 0.04779219627380371, -0.15338510274887085, 0.07786811143159866, 0.18398651480674744, 0.037669189274311066, -0.04580814391374588, -0.006490963976830244, 0.050098273903131485, -0.14785945415496826, 0.1609623283147812, 0.04798046872019768, 0.047632861882448196, 0.012631295248866081, -0.0022026710212230682, -0.11504396051168442, -0.14493343234062195, 0.24853472411632538, -0.0681559145450592, -0.11064682900905609, 0.1215883195400238, -0.011531593278050423, -1.31381873837698e-32, -0.06629282236099243, -0.013837689533829689, 0.0051431842148303986, -0.10151396691799164, -0.043578650802373886, 0.1217576414346695, 0.12781935930252075, -0.14171102643013, 0.11328786611557007, -0.23070624470710754, -0.021246764808893204, -0.036028455942869186, -0.012337939813733101, -0.05945182219147682, -0.03966369107365608, 0.0077944910153746605, -0.0525180846452713, -0.09254037588834763, -0.018204811960458755, 0.04551467299461365, 0.07059846818447113, 0.13880181312561035, 0.06500935554504395, 0.07788156718015671, 0.09021000564098358, -0.01474863663315773, 0.11310987174510956, 0.0814259722828865, -0.031864188611507416, 0.09150925278663635, -0.17632916569709778, 0.09639054536819458, -0.23321746289730072, 0.038977041840553284, -0.13210582733154297, 0.04490932822227478, -0.0179193876683712, -0.2872120141983032, -0.11180545389652252, -0.017061807215213776, 0.04424910247325897, 0.07278494536876678, 0.11973847448825836, -0.011139832437038422, 0.02316932938992977, 0.024191532284021378, 0.09704940021038055, 0.008900467306375504, 0.11547063291072845, -0.10028500109910965, -0.07419030368328094, 0.008097192272543907, 0.057297587394714355, 0.06449615955352783, -0.18940284848213196, 0.07216670364141464, 0.09982411563396454, 0.04429212585091591, -0.1356935054063797, 0.0836072489619255, 0.051051460206508636, 0.044234391301870346, 0.058322593569755554, -0.05603615939617157, 0.110429547727108, 0.09770765900611877, 0.052291158586740494, -0.038392432034015656, 0.04828627407550812, -0.12465594708919525, -0.007075483910739422, -0.1161189079284668, -0.198898583650589, -0.09023363888263702, 0.07531164586544037, 0.10975715517997742, -0.008315256796777248, 0.02012654021382332, -0.08683247119188309, -0.014374196529388428, 0.11260352283716202, 0.0223331730812788, -0.06825067102909088, 0.15642467141151428, 0.08122345805168152, 0.0519934818148613, 0.008543655276298523, -0.07195071130990982, -0.02371254190802574, 0.08206057548522949, -0.19026517868041992, -0.07974126935005188, 0.011214794591069221, 0.1834946870803833, -0.06600833684206009, -1.0124411886636153e-07, 0.10472694039344788, 0.022946197539567947, 0.013042637147009373, -0.09094162285327911, 0.1162327453494072, -0.2137508988380432, -0.1252993941307068, 0.12905439734458923, 0.022077705711126328, 0.1278117299079895, -0.05921030789613724, 0.3098447918891907, -0.10065878182649612, 0.03909333795309067, -0.13159416615962982, -0.007103659212589264, -0.10610724985599518, 0.15378642082214355, -0.061787910759449005, 0.04649646580219269, -0.1171858161687851, 0.09959672391414642, -0.03156958520412445, -0.15137699246406555, 0.03892563283443451, -0.1281363070011139, 0.02198624424636364, 0.11301571130752563, 0.007978876121342182, -0.0986948162317276, 0.00046900357119739056, 0.03450774401426315, 0.11632610112428665, -0.009329089894890785, -0.17087076604366302, -0.2064765840768814, 0.04659366235136986, 0.09971171617507935, 0.023524777963757515, 0.1346951723098755, 0.016617365181446075, -0.017102748155593872, 0.022022873163223267, -0.06672865152359009, -0.10653379559516907, 0.0691564604640007, -0.19642436504364014, -0.005585225764662027, 0.06009921431541443, -0.18716230988502502, -0.06531116366386414, 0.01898883283138275, -0.09010010957717896, 0.006558642722666264, -0.09307388961315155, 0.09720432758331299, -0.012436723336577415, 0.013726706616580486, 0.015052824281156063, -0.032152775675058365, 0.05991150811314583, -0.20764753222465515, -0.011250913143157959, -0.012232756242156029], "changes": {"1wk": -6.4128198296993695}}, {"text": "Aviceda Therapeutics Raises Upsized $207.5 Million in Series C Financing Round to Advance Lead Program AVD-104 for Geographic Atrophy into Pivotal Trials Business Wire Tue, Jan 7, 2025, 3:00 PM 4 min read Financing co-led by Omega Funds and TCGX, with significant participation from Enavate Sciences and Jeito Capital, alongside Longitude Capital, Blue Owl Healthcare Opportunities, and other leading investment firms Proceeds to advance late-stage AVD-104 program with first-in-class dual mechanism into pivotal clinical trials Twelve-month data from fully enrolled Phase 2b/3 trial evaluating AVD-104 in geographic atrophy anticipated in the second half of 2025 Bernard Davitian, Chen Yu and Evelyn Harrison to join Aviceda Board of Directors CAMBRIDGE, Mass., January 07, 2025 --( BUSINESS WIRE )--Aviceda Therapeutics (\"Aviceda\"), a private, clinical-stage biotech company focused on developing next-generation immunomodulators with a proprietary High Affinity Ligands of Siglecs (HALOS\u2122) nanotechnology platform to alleviate chronic, non-resolving inflammation, today announced the closing of a $207.5 million Series C financing. Proceeds will support the ongoing Phase 2b/3 and planned pivotal Phase 3 clinical trial for AVD-104 in geographic atrophy (GA), a vision-threatening condition secondary to advanced age-related macular degeneration, and the expansion into other ophthalmic indications. The Series C round was co-led by renowned healthcare funds, Omega Funds and TCGX, with participation from leading investment firms Enavate Sciences, Jeito Capital, Blue Owl Healthcare Opportunities, Longitude Capital, OrbiMed, Logos Capital, Marshall Wace, Catalio Capital Management, funds managed by abrdn Inc., and Digitalis Ventures. \"We are proud to support Aviceda and its team of retinal specialists, whose blend of ophthalmic expertise and operational excellence drives Aviceda\u2019s advancement of AVD-104 toward critical milestones,\" commented Bernard Davitian, Partner at Omega Funds. AVD-104\u2019s dual mechanism of action targets immune modulation and complement inhibition. By repolarizing overactivated macrophages to their healing stage and stabilizing complement factor H, AVD-104 has shown positive proof-of-concept efficacy in slowing GA lesion growth and preserving/enhancing visual function in a Phase 2a trial completed in early 2024, which underscores its potential for first-in-class efficacy and safety. Aviceda\u2019s ongoing Phase 2b/3 trial evaluating two doses of AVD-104 versus avacincaptad pegol (Izervay) in patients with GA is fully enrolled , with 12-month primary endpoint data anticipated in the second half of 2025. Chen Yu, M.D., M.B.A., Founder and Managing Partner at TCGX, added, \"Aviceda\u2019s focus on data quality and execution is evident in the progress of the AVD-104 program, and we believe the company is poised for significant impact in the geographic atrophy field with strong potential upside as it advances into a pivotal study.\" Story Continues In connection with the Series C financing, Bernard Davitian of Omega Funds and Chen Yu, M.D., M.B.A., of TCGX have joined Aviceda\u2019s Board of Directors. Evelyn Harrison, M.B.A., former Chief Operating Officer of Iveric Bio (part of Astellas Pharma Inc.) has also joined as an independent director, bringing valuable expertise in advancing novel therapies through late-stage clinical development and commercialization. In addition, Sara Nayeem, M.D. of Enavate Sciences and Rafa\u00e8le Tordjman, M.D. Ph.D. of Jeito Capital are appointed Board Observers. David Guyer, M.D., Board Chair of Aviceda, said, \"We are pleased to welcome our new board members and a syndicate of top institutional investors. This raise reflects the strong conviction from investors in Aviceda\u2019s lead program AVD-104 for geographic atrophy\u2014a market poised for disruption and an improved standard of care, given current treatments offer limited benefits in visual improvements, lesion control, and safety. With this upsized financing, the company is well-capitalized to advance a pivotal program for AVD-104 in GA.\" Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo, P.C. is acting as legal counsel to Aviceda, with Cooley LLP representing Omega Funds and Foley & Lardner LLP advising TCGX. Leerink Partners served as financial advisor to Aviceda. About Aviceda Therapeutics and AVD-104 Aviceda is a private, clinical-stage biotechnology company located in Cambridge, MA, with a proprietary High Affinity Ligands of Siglecs (HALOS\u2122) nanotechnology platform and a clinical-stage ophthalmic candidate, AVD-104, for the treatment of geographic atrophy secondary to age-related macular degeneration. AVD-104 is an intravitreal glycan-coated nanoparticle with a dual mechanism of action that modulates critical inflammatory cellular and complement pathways through 1) direct deactivation of inflammatory microglia/macrophages\u2019 phagocytic activity and repolarization of these activated microglia/macrophages to their healing state and 2) inhibition of complement cascade amplification. Along with AVD-104, Aviceda has a broad pipeline of products in development in ophthalmology and multiple other therapeutic areas, including immunology, fibrosis, oncology, and neurology. Learn more about Aviceda Therapeutics and follow the company on LinkedIn . View source version on businesswire.com: https://www.businesswire.com/news/home/20250107381552/en/ Contacts Media Contact Priyanka Shah Elephant Head Communications, LLC Email: PShah@elephantheadcommunicationsllc.com Phone: +1-908-447-6134 View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "AVD", "date": "2025-01-07T12:00:00+00:00", "sentiment": {"score": 0.7359384372830391, "confidence": 0.74471515417099, "probabilities": {"positive": 0.74471515417099, "negative": 0.008776716887950897, "neutral": 0.24650809168815613}}, "embedding": [-0.007187626324594021, -0.15943846106529236, -0.018621157854795456, -0.04678696393966675, 0.004807962104678154, -0.012529299594461918, -0.005569448694586754, 0.10603480041027069, 0.08273138105869293, 0.11551013588905334, -0.14284688234329224, 0.01419154368340969, -0.03580526262521744, -0.04354572296142578, -0.06825722008943558, 0.05919425189495087, -0.028621701523661613, 0.058121565729379654, -0.12336049973964691, 0.021492086350917816, 0.02208668366074562, -0.036472346633672714, -0.007800919935107231, -0.03966595232486725, -0.0890287309885025, 0.02371901646256447, -0.093074269592762, -0.04390503466129303, -0.1447141170501709, -0.07429427653551102, 0.016273703426122665, 0.1288716197013855, 0.004764246288686991, -0.01180553250014782, 8.95252451300621e-05, -0.003280813107267022, -0.21143513917922974, 0.05808296427130699, -0.2618925869464874, -0.09445889294147491, -0.07383036613464355, 0.0012954892590641975, -0.184559166431427, -0.009794320911169052, 0.039188385009765625, -0.16769228875637054, -0.09706622362136841, -0.01745576038956642, 0.013391543179750443, 0.13285419344902039, -0.18979021906852722, -0.12378158420324326, 0.021989692002534866, 0.0346158966422081, -0.09575915336608887, 0.16201670467853546, -0.16109627485275269, -0.10460123419761658, 0.05346107482910156, 0.014583180658519268, 0.05338737368583679, -0.08240579068660736, 0.042806535959243774, -0.04479110985994339, 0.031760625541210175, -0.038917846977710724, 0.10591516643762589, -0.10298794507980347, -0.044422540813684464, -0.13612018525600433, 0.020847706124186516, -0.13572055101394653, -0.001574959373101592, 0.184054434299469, 0.06571165472269058, 0.1428244560956955, 0.09350603073835373, -0.003812389215454459, 0.21262794733047485, -0.05277574807405472, 0.10412843525409698, 0.09146285057067871, 0.19924932718276978, 0.0533953458070755, 0.025055214762687683, -0.016224993392825127, -0.040037449449300766, 0.16600841283798218, 0.02990141324698925, 0.060059454292058945, 0.06205331161618233, 0.006012210622429848, 0.02342180907726288, 0.010990974493324757, 0.08651605248451233, 0.008809715509414673, -0.10628439486026764, -0.059981659054756165, 0.06437353789806366, 0.015718908980488777, -0.028352977707982063, -0.049674272537231445, -0.04634824022650719, -0.08429224789142609, 0.03299601748585701, -0.08874671906232834, 0.11052560061216354, -0.09034544229507446, 0.11606797575950623, 0.02798149734735489, -0.021841546520590782, 0.03392104059457779, 0.006195051595568657, -0.009766851551830769, -0.034681279212236404, 0.2495112270116806, -0.04243463650345802, 0.019223887473344803, 0.2069215029478073, -0.10311883687973022, 0.13096900284290314, -0.02377491444349289, 0.045696109533309937, -0.09803193062543869, 0.06892777979373932, 0.08349449187517166, -0.09827866405248642, 1.0304192461476164e-32, -0.0033432142809033394, 0.016360614448785782, -0.025152401998639107, 0.0638534277677536, 0.011536480858922005, -0.0681396871805191, 0.1328611671924591, 0.1288369596004486, -0.20855599641799927, -0.048216886818408966, -0.18724781274795532, -0.009406905621290207, 0.01914900355041027, 0.21710771322250366, -0.02154439501464367, -0.11256948858499527, -5.371030420064926e-05, 0.019521702080965042, -0.03782910481095314, -0.04648348689079285, 0.027787119150161743, 0.04776788502931595, 0.007116180844604969, 0.11093197017908096, 0.05925576388835907, 0.05281420052051544, -0.14507189393043518, 0.06995166093111038, 0.16574907302856445, 0.0623101070523262, -0.07346450537443161, 0.11441297084093094, 0.012251661159098148, -0.1543843150138855, -0.032698698341846466, -0.007275663316249847, -0.03045046329498291, -0.05483926087617874, 0.049315329641103745, 0.0478200763463974, 0.06609891355037689, 0.14428311586380005, -0.12150496244430542, -0.12992370128631592, 0.022529343143105507, -0.08340367674827576, -0.08263258635997772, 0.02633032575249672, -0.03008333221077919, 0.06345148384571075, -0.0095723457634449, -0.0231756791472435, -0.031779468059539795, -0.09216973185539246, 0.018594104796648026, 0.10755089670419693, -0.1646842211484909, 0.060312382876873016, 0.048729851841926575, 0.036174044013023376, -0.025989562273025513, -0.008606444112956524, 0.03139099106192589, 0.12749379873275757, -0.05499548465013504, 0.07312659919261932, 0.08699215948581696, -0.028403248637914658, -0.22961193323135376, 0.055333737283945084, 0.007615221198648214, -0.05452374368906021, 0.11248636245727539, -0.02508966252207756, 0.05219002068042755, -0.12210822850465775, 0.05300620198249817, 0.09192557632923126, -0.042767077684402466, -0.023767365142703056, 0.023033201694488525, 0.23070527613162994, -0.051131680607795715, 0.14271855354309082, 0.007252981886267662, -0.13748261332511902, 0.029718488454818726, 0.016233481466770172, -0.15831276774406433, -0.13359972834587097, 0.19765909016132355, -0.03781506419181824, -0.07559004426002502, 0.11153318732976913, -0.0811084434390068, -1.1111520512252972e-32, -0.09478636085987091, -0.09554924815893173, -0.09156018495559692, -0.030230648815631866, -0.043536100536584854, 0.11939302831888199, 0.1569824516773224, -0.0984036847949028, 0.127975732088089, -0.18282489478588104, 0.0896545946598053, 0.03146715834736824, -0.09170641750097275, -0.05096477270126343, -0.07795560359954834, 0.04692351073026657, -0.04681534320116043, -0.01768483594059944, -0.11015389859676361, 0.036651693284511566, -0.019917311146855354, 0.18345898389816284, 0.05811358243227005, 0.028499403968453407, 0.0803961232304573, -0.003974567167460918, 0.11148781329393387, 0.012242581695318222, -0.00584558118134737, 0.06434733420610428, -0.12381987273693085, 0.054313186556100845, -0.16762006282806396, 0.018122801557183266, -0.017734499648213387, 0.04467179998755455, 0.03639379143714905, -0.21242648363113403, -0.13502535223960876, -0.07584328949451447, 0.09025762975215912, -0.018490636721253395, 0.03235628083348274, -0.016857512295246124, 0.06246262043714523, 0.03980112075805664, 0.052100084722042084, 0.014241617172956467, 0.08469055593013763, -0.044772274792194366, -0.01646256074309349, -0.05056658387184143, 0.06950864940881729, 0.04341324046254158, -0.09324755519628525, 0.0053550200536847115, 0.11162638664245605, 0.045553602278232574, -0.10300107300281525, -0.03121151030063629, -0.026875996962189674, 0.03929974511265755, 0.13013511896133423, -0.017477313056588173, 0.1227663904428482, 0.21303604543209076, 0.08330981433391571, 0.0342177152633667, 0.031047914177179337, -0.18623775243759155, -0.05733085796236992, -0.0526253804564476, -0.10698755830526352, -0.037067729979753494, 0.03760448843240738, 0.0909988135099411, 0.015825627371668816, -0.0006938427686691284, -0.15730321407318115, 0.011386514641344547, 0.03201704099774361, 0.004473328590393066, -0.04871264845132828, 0.08573503792285919, 0.05922824144363403, 0.0859837681055069, 0.014659544453024864, 0.0069763511419296265, -0.026055114343762398, 0.0897458866238594, -0.1782788783311844, -0.07953640073537827, -0.05550885573029518, 0.08780919760465622, -0.06941933184862137, -1.0091295621350582e-07, 0.15418089926242828, 0.026526547968387604, 0.04373721778392792, -0.15414509177207947, 0.04340360313653946, -0.028988510370254517, -0.06256910413503647, 0.10523772239685059, -0.02014080621302128, 0.1045083999633789, -0.002001277171075344, 0.19698357582092285, -0.03210773319005966, 0.023776575922966003, 0.0023544859141111374, 0.013837927021086216, -0.0586673803627491, 0.0854262039065361, -0.0710185095667839, 0.0008834381587803364, -0.17944809794425964, 0.11113357543945312, -0.04631364345550537, -0.12750256061553955, 0.07167612016201019, -0.11896567046642303, 0.02094574272632599, 0.04655276611447334, 0.059280749410390854, -0.09584589302539825, -0.005419398657977581, 0.011927032843232155, 0.08671797811985016, 0.02375841699540615, -0.08830894529819489, -0.18035826086997986, 0.08213192224502563, 0.056048259139060974, 0.05132187902927399, 0.14382624626159668, -0.0002741031348705292, 0.06783038377761841, -0.002562155481427908, -0.05164218693971634, -0.06889636814594269, 0.009871609508991241, -0.12823596596717834, -0.007696343585848808, 0.09096339344978333, -0.06730130314826965, -0.09793360531330109, 0.012452860362827778, -0.07263696193695068, -0.012376073747873306, -0.12615519762039185, 0.052683234214782715, -0.034075260162353516, -0.07906582206487656, 0.04454915225505829, -0.09826360642910004, -0.0011066831648349762, -0.14279420673847198, 0.0072560058906674385, 0.033686310052871704], "changes": {"1wk": -6.4128198296993695}}, {"text": "The past five years for American Vanguard (NYSE:AVD) investors has not been profitable editorial-team@simplywallst.com (Simply Wall St) Thu, Dec 26, 2024, 3:23 PM 2 min read In This Article: AVD -1.62% Long term investing is the way to go, but that doesn't mean you should hold every stock forever. It hits us in the gut when we see fellow investors suffer a loss. For example, we sympathize with anyone who was caught holding American Vanguard Corporation ( NYSE:AVD ) during the five years that saw its share price drop a whopping 77%. And it's not just long term holders hurting, because the stock is down 61% in the last year. Unfortunately the share price momentum is still quite negative, with prices down 27% in thirty days. So let's have a look and see if the longer term performance of the company has been in line with the underlying business' progress. View our latest analysis for American Vanguard While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price. In the last half decade American Vanguard saw its share price fall as its EPS declined below zero. At present it's hard to make valid comparisons between EPS and the share price. However, we can say we'd expect to see a falling share price in this scenario. You can see how EPS has changed over time in the image below (click on the chart to see the exact values). NYSE:AVD Earnings Per Share Growth December 26th 2024 We like that insiders have been buying shares in the last twelve months. Even so, future earnings will be far more important to whether current shareholders make money. Before buying or selling a stock, we always recommend a close examination of historic growth trends, available here. . A Different Perspective Investors in American Vanguard had a tough year, with a total loss of 61% (including dividends), against a market gain of about 26%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Unfortunately, last year's performance may indicate unresolved challenges, given that it was worse than the annualised loss of 12% over the last half decade. We realise that Baron Rothschild has said investors should \"buy when there is blood on the streets\", but we caution that investors should first be sure they are buying a high quality business. It's always interesting to track share price performance over the longer term. But to understand American Vanguard better, we need to consider many other factors. Consider risks, for instance. Every company has them, and we've spotted 2 warning signs for American Vanguard you should know about. Story Continues There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of undervalued small cap companies that insiders are buying. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "AVD", "date": "2024-12-26T12:23:45+00:00", "sentiment": {"score": -0.8995621353387833, "confidence": 0.9180711507797241, "probabilities": {"positive": 0.018509015440940857, "negative": 0.9180711507797241, "neutral": 0.06341984122991562}}, "embedding": [0.011624479666352272, -0.05305459350347519, 0.04549922049045563, 0.007616125512868166, 0.11835657060146332, -0.0045355805195868015, -0.0362301766872406, 0.012682406231760979, 0.12233857810497284, 0.06090209633111954, -0.14372879266738892, 0.17977315187454224, -0.05927405133843422, -0.07052679359912872, -0.13685846328735352, -0.12451234459877014, -0.045221030712127686, -0.020186897367239, -0.027859201654791832, 0.07151377201080322, -0.11333831399679184, -0.13246428966522217, 0.016852397471666336, 0.04004046693444252, 0.10990913212299347, -0.038699548691511154, -0.01403394341468811, -0.012717647477984428, -0.09737831354141235, -0.09091989696025848, -0.12852169573307037, -0.018487663939595222, 0.07697074860334396, 0.05257111042737961, -0.15440644323825836, 0.019973447546362877, 0.12778925895690918, 0.07810741662979126, 0.024485712870955467, -0.06553158164024353, -0.03383709490299225, -0.1117902472615242, -0.12052248418331146, -0.012158486060798168, -0.03984730690717697, -0.014955803751945496, -0.012694091536104679, 0.02809576690196991, 0.024952128529548645, 0.08360813558101654, -0.0685916543006897, -0.03051215037703514, 0.08454863727092743, -0.06020429730415344, -0.08739331364631653, 0.0685935690999031, -0.07331422716379166, -0.01915235072374344, 0.11498039960861206, 0.021406786516308784, 0.012974346056580544, -0.03506249934434891, 0.040933139622211456, 0.04207831621170044, 0.06644744426012039, -0.0711134746670723, 0.10699886083602905, 0.03901401162147522, -0.09608379751443863, 0.0693507194519043, 0.06773398071527481, 0.005489794071763754, -0.07933938503265381, -0.045266903936862946, -0.10095024853944778, 0.13995058834552765, 0.11274702101945877, -0.04716324061155319, 0.08605097979307175, -0.021836990490555763, 0.12414763867855072, 0.1326267570257187, 0.01710101030766964, -0.04375208169221878, -0.004450289532542229, -0.009259897284209728, 0.14892403781414032, -0.009634533897042274, 0.02433306723833084, -0.06546106934547424, 0.051496896892786026, -0.08554854989051819, -0.10103005915880203, -0.02124156430363655, 0.18385539948940277, 0.051241178065538406, -0.09871596097946167, 0.013375550508499146, -0.1041015088558197, 0.06786908954381943, 0.08720055222511292, 0.10452267527580261, -0.07497614622116089, -0.09232896566390991, -0.020439306274056435, -0.047019585967063904, 0.09964615851640701, -0.05825395882129669, 0.04766841232776642, 0.029449550434947014, -0.07202979177236557, 0.10812634229660034, -0.13584603369235992, -0.058896902948617935, 0.05253933370113373, -0.08632294833660126, -0.07528848946094513, -0.06324534118175507, 0.00028740917332470417, 0.024864163249731064, 0.08188796043395996, 0.15729892253875732, -0.006614853627979755, 0.07562225311994553, -0.0265047587454319, 0.06626785546541214, -0.06772743165493011, 1.1479862401767105e-32, 0.011006245389580727, 0.0031410222873091698, 0.0020702220499515533, 0.03712102398276329, -0.1543208658695221, 0.05219113454222679, -0.0070959231816232204, -0.008383402600884438, -0.08380111306905746, -0.0769410952925682, -0.06003642827272415, 0.03577176481485367, -0.05519251525402069, 0.010666455142199993, 0.105818010866642, -0.027227677404880524, 0.038186270743608475, 0.05078687146306038, 0.09567800164222717, -0.06967007368803024, -0.005892124027013779, -0.025802969932556152, -0.03648420050740242, -0.03995203599333763, 0.13579115271568298, -0.12309876084327698, -0.09844985604286194, 0.04511937499046326, -0.10428786277770996, 0.007139955647289753, -0.04659220576286316, 0.03763366490602493, -0.09655259549617767, -0.048019811511039734, -0.026213375851511955, -0.07711971551179886, -0.015371494926512241, 0.07862314581871033, 0.0880005955696106, -0.07245522737503052, -0.09918449074029922, 0.10956902801990509, -0.09448501467704773, -0.05878763645887375, 0.019099250435829163, 0.004371346440166235, 0.0401444174349308, 0.029400575906038284, -0.07378160953521729, -0.015763498842716217, 0.007720693945884705, 0.02783813141286373, -0.05845670774579048, -0.02580280601978302, -0.010719506070017815, 0.12881992757320404, 0.04004323482513428, -0.12058950215578079, 0.018955783918499947, 0.029899967834353447, 0.05643809586763382, 0.1880025565624237, -0.012198986485600471, -0.0004438632167875767, -0.2705402374267578, 0.1859370470046997, -0.00498210359364748, 0.10592648386955261, -0.16010785102844238, 0.20173786580562592, -0.06346559524536133, -0.012309057638049126, 0.013789679855108261, -0.10049274563789368, 0.08677925169467926, -0.040260933339595795, 0.013821263797581196, 0.04813859611749649, 0.09432773292064667, 0.033880606293678284, -0.0034257490187883377, -0.03754742071032524, 0.08446131646633148, -0.04099150002002716, -0.050060808658599854, 0.031830426305532455, 0.10422083735466003, -0.040037401020526886, -0.08647061139345169, -0.01835736818611622, 0.05224674940109253, -0.04792517423629761, 0.066102534532547, 0.18497273325920105, -0.04474298655986786, -1.2076617537325394e-32, -0.0947505384683609, -0.06247853487730026, -0.014295129105448723, 0.0010091634467244148, -0.10930977016687393, -0.0341808944940567, 0.06824707239866257, 0.1480608880519867, -0.10127819329500198, -0.13942503929138184, -0.0021387245506048203, -0.007033310364931822, -0.10166288167238235, 0.12188179045915604, -0.06806432455778122, -0.03133301064372063, 0.06862489879131317, -0.12290261685848236, 0.14740507304668427, -0.051047433167696, -0.0013767207274213433, 0.19000914692878723, -0.04202384501695633, 0.026826022192835808, 0.02451878786087036, 0.013527230359613895, 0.04033854976296425, 0.1280190497636795, -0.03042072430253029, -0.13748778402805328, 0.01616516523063183, 0.021735437214374542, -0.006917262449860573, 0.10298223793506622, 0.00041222479194402695, 0.06928254663944244, -0.019274042919278145, -0.11805593967437744, -0.011578930541872978, 0.07119950652122498, 0.06382730603218079, 0.09163691103458405, 0.0803668349981308, -0.06511372327804565, 0.06517159938812256, 0.052564457058906555, 0.10453354567289352, 0.01573196053504944, 0.09960324317216873, 0.01612345688045025, 0.03579806536436081, -0.07114873826503754, -0.08097325265407562, 0.17026051878929138, -0.13094612956047058, 0.07314390689134598, -0.10906431078910828, 0.02089834213256836, -0.12595020234584808, 0.0845002830028534, -0.11774099618196487, 0.14602932333946228, 0.039430782198905945, 0.07110603153705597, 0.01595460996031761, -0.05621195584535599, -0.03497207909822464, -0.05480339378118515, -0.0015755444765090942, -0.016283411532640457, 0.05815991014242172, -0.07576794922351837, -0.06652698665857315, -0.0005252044647932053, 0.08107452839612961, 0.08657041192054749, 0.01543026976287365, -0.04947103559970856, 0.013464040122926235, 0.07404009997844696, -0.030636489391326904, 0.07175494730472565, -0.07825638353824615, 0.02113323286175728, -0.18059572577476501, 0.192170649766922, 0.021800361573696136, -0.05282972753047943, -0.08191485702991486, 0.014193885028362274, -0.03557443618774414, -0.09850896894931793, -0.0830044150352478, -0.0699593648314476, 0.008947208523750305, -9.987590487980924e-08, 0.046047814190387726, -0.03358059749007225, 0.0987328588962555, -0.036770500242710114, 0.04065198451280594, -0.1235576719045639, 0.10443933308124542, -0.08856746554374695, 0.016356904059648514, 0.11872071027755737, 0.050896577537059784, 0.024646714329719543, -0.1601373553276062, -0.06137643754482269, -0.12329551577568054, -0.03354833647608757, -0.12085976451635361, 0.08721195161342621, -0.02232971042394638, -0.01599278673529625, 0.1437438726425171, 0.10338078439235687, 0.042897339910268784, -0.0038520991802215576, 0.0009040781296789646, -0.0036569260992109776, 0.033816076815128326, -0.08269128203392029, -0.11112545430660248, 0.07317748665809631, -0.007114659994840622, -0.013000963255763054, 0.034415535628795624, -0.01006109919399023, 0.01576276868581772, 0.04633519425988197, -0.005295801907777786, 0.07365585118532181, 0.050161246210336685, 0.16614314913749695, -0.03581104427576065, 0.07407530397176743, 0.07904861122369766, -0.08063723146915436, -0.08387830853462219, -0.03833267092704773, -0.095688596367836, 0.004325505346059799, 0.026977375149726868, -0.1343841850757599, 0.1370665729045868, -0.007694858592003584, 0.0115808742120862, 0.13319288194179535, 0.03860017657279968, -0.07357260584831238, -0.11322934925556183, -0.050356075167655945, -0.15094557404518127, -0.05806504935026169, 0.04651038721203804, -0.23643171787261963, -0.055923305451869965, 0.20861461758613586], "changes": {"1wk": 1.5350915030649859, "1mo": 24.122805228854126}}, {"text": "American Vanguard (AVD) Reports Q3 Loss, Misses Revenue Estimates Zacks Equity Research Tue, Nov 12, 2024, 1:55 AM 3 min read In This Article: AVD -1.62% American Vanguard (AVD) came out with a quarterly loss of $0.69 per share versus the Zacks Consensus Estimate of a loss of $0.10. This compares to loss of $0.01 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -590%. A quarter ago, it was expected that this agricultural products company would post a loss of $0.01 per share when it actually produced a loss of $0.09, delivering a surprise of -800%. Over the last four quarters, the company has surpassed consensus EPS estimates just once. American Vanguard , which belongs to the Zacks Chemical - Specialty industry, posted revenues of $118.31 million for the quarter ended September 2024, missing the Zacks Consensus Estimate by 14.52%. This compares to year-ago revenues of $149.52 million. The company has not been able to beat consensus revenue estimates over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. American Vanguard shares have lost about 47.4% since the beginning of the year versus the S&P 500's gain of 25.7%. What's Next for American Vanguard? While American Vanguard has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for American Vanguard: mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $0.13 on $169.1 million in revenues for the coming quarter and -$0.34 on $570.9 million in revenues for the current fiscal year. Story Continues Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Chemical - Specialty is currently in the bottom 36% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. One other stock from the same industry, Perimeter Solutions, SA (PRM), is yet to report results for the quarter ended September 2024. The results are expected to be released on November 12. This company is expected to post quarterly earnings of $0.61 per share in its upcoming report, which represents a year-over-year change of +96.8%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. Perimeter Solutions, SA's revenues are expected to be $265.3 million, up 86% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report American Vanguard Corporation (AVD) : Free Stock Analysis Report Perimeter Solutions, SA (PRM) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "AVD", "date": "2024-11-11T22:55:02+00:00", "sentiment": {"score": -0.5864592120051384, "confidence": 0.6707617044448853, "probabilities": {"positive": 0.08430249243974686, "negative": 0.6707617044448853, "neutral": 0.2449357956647873}}, "embedding": [-0.02668265998363495, -0.01543109305202961, -0.05211062729358673, 0.09335433691740036, 0.12454433739185333, -0.020048417150974274, -0.08129221200942993, 0.05516298860311508, 0.23912319540977478, 0.13493137061595917, -0.1295260488986969, 0.17034456133842468, -0.025563057512044907, -0.10142579674720764, -0.16405045986175537, -0.12660738825798035, 0.012047986499965191, -0.03742900490760803, -0.05572153255343437, 0.02577383443713188, -0.08445106446743011, 0.03227084130048752, 0.1253153681755066, 0.1215764582157135, 0.18235929310321808, -0.0031306801829487085, -0.10028497874736786, 0.001243704929947853, -0.1519300788640976, -0.1533982902765274, -0.1528824269771576, 0.02460741251707077, 0.0869896188378334, -0.04219701886177063, -0.1090310662984848, -0.04482891783118248, 0.10403437167406082, 0.08485552668571472, 0.025813469663262367, -0.08500069379806519, -0.03810255229473114, -0.08342573046684265, -0.16318324208259583, -0.03257794678211212, -0.013448362238705158, -0.01708887331187725, -0.11355040222406387, 0.044991638511419296, 0.03019937127828598, 0.07188917696475983, -0.045861758291721344, -0.037023745477199554, 0.053874123841524124, 0.014717919752001762, -0.08898773789405823, 0.11039811372756958, -0.056276436895132065, -0.034666743129491806, 0.11284533143043518, 0.07346288114786148, 0.019913244992494583, -0.01341952383518219, 0.042308516800403595, 0.07763498276472092, 0.09271533787250519, -0.09663757681846619, 0.04280194640159607, 0.02643490582704544, -0.12210901081562042, 0.014687811955809593, 0.06693079322576523, -0.012134892866015434, -0.09351791441440582, -0.00561404088512063, -0.056721657514572144, 0.10364795476198196, 0.18358324468135834, 0.021679693832993507, 0.0948956310749054, -0.017650458961725235, 0.12692788243293762, 0.046598270535469055, 0.0011625266633927822, -0.07427109777927399, 0.039626479148864746, 0.009244885295629501, 0.14467734098434448, 0.08015823364257812, 0.07595247030258179, -0.013478945940732956, -0.11424022912979126, -0.12256862223148346, -0.0575903058052063, -0.03179458528757095, 0.128553107380867, 0.01707102358341217, -0.013680599629878998, -0.09024713188409805, -0.04077751189470291, 0.07935917377471924, 0.12121953815221786, 0.11468289792537689, -0.06549158692359924, -0.14476041495800018, 0.007343431003391743, -0.04866597801446915, 0.08584335446357727, -0.010602902621030807, 0.056360334157943726, 0.05796525627374649, 0.02732173725962639, 0.08757972717285156, -0.20682798326015472, -0.09493193030357361, -0.0037026675418019295, 0.015170365571975708, -0.04163310304284096, 0.021936070173978806, 0.046889983117580414, 0.11415191739797592, 0.04712619632482529, 0.14718687534332275, 0.009271619841456413, 0.08597990870475769, -0.019011735916137695, 0.0839027613401413, -0.12533655762672424, 7.264017299416236e-33, 0.05178680270910263, 0.0583258718252182, -0.00037513021379709244, -0.037980273365974426, -0.06621166318655014, 0.034057047218084335, 0.07515233755111694, -0.032158732414245605, -0.015376878902316093, -0.11929865926504135, -0.10577867925167084, 0.12046149373054504, -0.060189247131347656, 0.07383447885513306, 0.03485420346260071, -0.12215973436832428, 0.027738910168409348, 0.10823941230773926, 0.0793980062007904, -0.08726923167705536, -0.009577950462698936, -0.06295017153024673, -0.06931149959564209, 0.02590206265449524, 0.13599082827568054, -0.05467885732650757, -0.1151597797870636, 0.012151345610618591, -0.1673106849193573, 0.013970120809972286, -0.043365251272916794, 0.07161632180213928, 0.024566709995269775, -0.11766500771045685, -0.056520476937294006, -0.08820963650941849, -0.019391421228647232, -0.007145954295992851, 0.08928607404232025, -0.006690433248877525, -0.06460756063461304, 0.16978925466537476, -0.10403529554605484, -0.17046397924423218, -0.0715232789516449, 0.0246015265583992, 0.05824802443385124, 0.0899035707116127, -0.0007614516653120518, -0.03938806429505348, -0.0022984128445386887, 0.05197705700993538, 0.022902576252818108, -0.054640986025333405, 0.00015608780086040497, 0.05599134415388107, 0.01049453392624855, -0.180038720369339, -0.012208103202283382, 0.03707032650709152, 0.08800869435071945, 0.3028668165206909, -0.03974681347608566, -0.027616340667009354, -0.2987840473651886, 0.16125184297561646, 0.04429047182202339, 0.09679602086544037, -0.18851149082183838, 0.27013278007507324, -0.03314397484064102, -0.03892096132040024, 0.09715737402439117, -0.02179764211177826, 0.19250524044036865, -0.08100542426109314, 0.008346021175384521, -0.017895299941301346, 0.15473121404647827, -0.02246471866965294, -0.023725546896457672, -0.02958713471889496, -0.0431973859667778, -0.0054117292165756226, -0.0753612220287323, 0.06382574141025543, 0.060498856008052826, 0.05935903266072273, 0.032623883336782455, -0.046688489615917206, 0.05703910440206528, -0.07733109593391418, 0.05020379275083542, 0.14888927340507507, -0.028993792831897736, -8.218044106439789e-33, -0.07337352633476257, 0.049902401864528656, -0.03546379134058952, 0.04011596366763115, -0.07141348719596863, -0.03927963227033615, 0.09433266520500183, 0.16627272963523865, -0.06260108947753906, -0.22736918926239014, -0.018203595653176308, -0.03710893541574478, -0.1948818415403366, 0.13993123173713684, -0.006352194119244814, -0.06535916775465012, 0.036985255777835846, -0.14443156123161316, 0.241374671459198, -0.00844824779778719, 0.03205595165491104, 0.1783621609210968, -0.025772541761398315, 0.06025883927941322, 0.06257770210504532, -0.04927889257669449, 0.007768591400235891, 0.20339785516262054, -0.05524882301688194, -0.16758963465690613, 0.062291234731674194, -0.09100252389907837, -0.03873949497938156, 0.1764957308769226, -0.057438768446445465, 0.05428706109523773, -0.0499921552836895, -0.0843212753534317, -0.03951338678598404, -0.004708295688033104, 0.09952036291360855, 0.02574334666132927, 0.07523276656866074, -0.020236916840076447, 0.004667247179895639, 0.08772808313369751, 0.070554718375206, 0.06373253464698792, 0.09597434103488922, -0.02798624336719513, 0.008165065199136734, -0.06768898665904999, -0.10203970968723297, 0.1987813115119934, -0.24076350033283234, 0.10511581599712372, -0.11095265299081802, 0.06645563989877701, -0.12612384557724, 0.0862174853682518, -0.021311819553375244, 0.19138073921203613, 0.019544467329978943, 0.08113516867160797, 0.04730197414755821, -0.03587360680103302, -0.024692103266716003, -0.021891016513109207, -0.04471413791179657, -0.03343803063035011, 0.014943140558898449, -0.10495834052562714, 0.08342219889163971, -0.05842260643839836, 0.08745565265417099, 0.1553541123867035, -0.037659142166376114, -0.1841069459915161, 0.006047711707651615, -0.013867936097085476, 0.0646369531750679, 0.08982336521148682, -0.05939502641558647, 0.03349614143371582, -0.1557554304599762, 0.2720397710800171, -0.008818638511002064, -0.07843903452157974, -0.06944597512483597, 0.04274908825755119, -0.10451340675354004, -0.10247160494327545, -0.12104002386331558, -0.025543073192238808, 0.003175138495862484, -9.97332634256054e-08, 0.13451993465423584, -0.0017436491325497627, 0.06314492225646973, -0.011300062760710716, 0.09309203922748566, -0.07427255809307098, 0.09523876011371613, -0.0764199048280716, 0.06499968469142914, 0.05374731868505478, -0.05088241770863533, -0.043238330632448196, -0.16444459557533264, -0.051448505371809006, -0.11269931495189667, -0.05624159052968025, -0.09348757565021515, 0.1286836564540863, -0.018052242696285248, -0.0991101861000061, 0.010711396113038063, 0.13358120620250702, 0.011103137396275997, -0.18565571308135986, 0.05833182483911514, -0.005947469733655453, -0.04771381616592407, -0.0374155230820179, -0.005733909085392952, 0.04661312699317932, 0.028833303600549698, -0.05098462477326393, 0.004954279400408268, 0.04188980162143707, -0.030952025204896927, -0.04519018530845642, -0.05681765452027321, 0.057422935962677, 0.014384124428033829, 0.07662708312273026, 0.021731387823820114, 0.018157459795475006, 0.0870165079832077, -0.04316879063844681, -0.12882816791534424, -0.08473289757966995, -0.14556698501110077, -0.055890437215566635, 0.011134122498333454, -0.18460166454315186, 0.1613037884235382, -0.13049927353858948, 0.0793292373418808, 0.1212901920080185, 0.09407641738653183, -0.0766436979174614, -0.11347229033708572, -0.13068945705890656, -0.14880234003067017, -0.11027736961841583, 0.09938730299472809, -0.30077099800109863, 0.006681142374873161, 0.22856205701828003], "changes": {"1wk": 8.657248430481184, "1mo": -3.8869221929792044}}, {"text": "American Vanguard Corporation (NYSE:AVD) Just Reported, And Analysts Assigned A US$12.50 Price Target editorial-team@simplywallst.com (Simply Wall St) Fri, Nov 15, 2024, 1:08 PM 3 min read In This Article: AVD -1.62% It's shaping up to be a tough period for American Vanguard Corporation ( NYSE:AVD ), which a week ago released some disappointing third-quarter results that could have a notable impact on how the market views the stock. Unfortunately, American Vanguard delivered a serious earnings miss. Revenues of US$118m were 15% below expectations, and statutory losses ballooned 868% to US$0.92 per share. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year. See our latest analysis for American Vanguard NYSE:AVD Earnings and Revenue Growth November 15th 2024 Taking into account the latest results, the current consensus from American Vanguard's two analysts is for revenues of US$591.3m in 2025. This would reflect an okay 6.8% increase on its revenue over the past 12 months. American Vanguard is also expected to turn profitable, with statutory earnings of US$0.42 per share. Yet prior to the latest earnings, the analysts had been anticipated revenues of US$598.8m and earnings per share (EPS) of US$0.40 in 2025. So the consensus seems to have become somewhat more optimistic on American Vanguard's earnings potential following these results. The consensus price target fell 17% to US$12.50, suggesting the increase in earnings forecasts was not enough to offset other the analysts concerns. Of course, another way to look at these forecasts is to place them into context against the industry itself. The period to the end of 2025 brings more of the same, according to the analysts, with revenue forecast to display 5.4% growth on an annualised basis. That is in line with its 5.7% annual growth over the past five years. Compare this with the broader industry, which analyst estimates (in aggregate) suggest will see revenues grow 4.5% annually. It's clear that while American Vanguard's revenue growth is expected to continue on its current trajectory, it's only expected to grow in line with the industry itself. The Bottom Line The most important thing here is that the analysts upgraded their earnings per share estimates, suggesting that there has been a clear increase in optimism towards American Vanguard following these results. Happily, there were no real changes to revenue forecasts, with the business still expected to grow in line with the overall industry. The consensus price target fell measurably, with the analysts seemingly not reassured by the latest results, leading to a lower estimate of American Vanguard's future valuation. Story Continues With that in mind, we wouldn't be too quick to come to a conclusion on American Vanguard. Long-term earnings power is much more important than next year's profits. At least one analyst has provided forecasts out to 2025, which can be seen for free on our platform here. Plus, you should also learn about the 3 warning signs we've spotted with American Vanguard . Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "AVD", "date": "2024-11-15T10:08:52+00:00", "sentiment": {"score": -0.797863133251667, "confidence": 0.8807771801948547, "probabilities": {"positive": 0.08291404694318771, "negative": 0.8807771801948547, "neutral": 0.03630869463086128}}, "embedding": [0.036618687212467194, -0.10045026242733002, -0.03276979178190231, 0.05139733850955963, 0.09581604599952698, -0.05096186697483063, -0.03434274345636368, 0.019731009379029274, 0.154830664396286, 0.07566691935062408, -0.1863432377576828, 0.21512320637702942, -0.07604993134737015, -0.062416210770606995, -0.15703922510147095, -0.07102091610431671, -0.04090322554111481, -0.07522202283143997, -0.04993986338376999, 0.08073366433382034, -0.009138553403317928, -0.0514238178730011, 0.043617114424705505, 0.021760258823633194, 0.15243196487426758, -0.06474583595991135, -0.04654986783862114, -0.08167266100645065, -0.12503859400749207, -0.08491182327270508, -0.12202594429254532, -0.023212365806102753, 0.10334771126508713, -0.03425431251525879, -0.10809484124183655, -0.03056730516254902, 0.153922900557518, 0.09302163124084473, 0.04837184399366379, -0.046520162373781204, 0.02870854176580906, -0.10339666157960892, -0.15126892924308777, 0.022922255098819733, -0.01844896748661995, 0.03535916283726692, -0.06512792408466339, 0.09766435623168945, -0.04661063849925995, 0.12311482429504395, -0.08488477021455765, -0.02360900118947029, 0.07187138497829437, -0.058967623859643936, -0.05927206575870514, 0.08990218490362167, -0.029071718454360962, -0.03641894832253456, 0.15976060926914215, -0.0020392751321196556, -0.09951873123645782, -0.008929302915930748, 0.05802852660417557, 0.07376286387443542, 0.1281731277704239, -0.14323729276657104, 0.06391875445842743, 0.04644103720784187, -0.19139070808887482, 0.011957023292779922, 0.05706886947154999, -0.02394784614443779, -0.04907679185271263, -0.053260501474142075, -0.06997650116682053, 0.13573217391967773, 0.14770740270614624, 0.005944922566413879, 0.10170817375183105, -0.033853016793727875, 0.1383144110441208, 0.06339661777019501, -0.018083395436406136, -0.11660421639680862, -0.052564579993486404, 0.02632047049701214, 0.1532539427280426, -0.01866012066602707, 0.07876450568437576, -0.038036078214645386, 0.016395434737205505, -0.14514991641044617, -0.11712907254695892, 0.03995253145694733, 0.10504250228404999, 0.020866431295871735, -0.07336461544036865, -0.10014812648296356, -0.0332910530269146, 0.06913712620735168, 0.10139359533786774, 0.08969046175479889, -0.0022048302926123142, -0.1155240535736084, -0.0696466863155365, -0.10092957317829132, 0.050099264830350876, -0.014998502098023891, 0.04006843641400337, 0.048110056668519974, -0.02532854676246643, 0.07153245061635971, -0.15194153785705566, -0.05949683487415314, 0.024860741570591927, -0.02931620366871357, -0.07169327884912491, -0.04408911615610123, 0.037271350622177124, -0.030304374173283577, 0.04759441316127777, 0.19885072112083435, 0.04560032859444618, 0.09712380170822144, -0.07044350355863571, -0.004736647009849548, -0.17800472676753998, 1.0171348375521798e-32, -0.011025732383131981, -0.011353571899235249, -0.0024774442426860332, -0.10005640983581543, -0.10615015029907227, 0.05507627874612808, 0.07812196761369705, 0.030486058443784714, -0.03703891858458519, -0.1256261169910431, -0.11767862737178802, 0.06549470871686935, -0.02259298972785473, 0.11521688103675842, 0.07306092977523804, -0.08165601640939713, 0.11068826168775558, 0.1420900821685791, 0.08414985984563828, -0.0668843686580658, 0.04351925477385521, -0.01993892341852188, -0.05468972027301788, 0.011536376550793648, 0.09059283882379532, -0.058051612228155136, -0.12752139568328857, 0.03085179254412651, -0.10507689416408539, 0.006529690232127905, -0.08731961250305176, 0.10709871351718903, 0.01048152707517147, -0.06874165683984756, 0.022944634780287743, -0.08433356881141663, -0.0019580507650971413, 0.06301376968622208, 0.05391605198383331, -0.015536565333604813, -0.04319513589143753, 0.12716513872146606, -0.04449501633644104, -0.16787046194076538, -0.020299626514315605, 0.01355741173028946, 0.0060515021905303, 0.05236845090985298, -0.05113176256418228, -0.0769675225019455, -0.02488011308014393, 0.05233234167098999, -0.015175807289779186, -0.0869869589805603, 0.06430244445800781, 0.051434919238090515, -0.012342609465122223, -0.15316104888916016, 0.06862540543079376, 0.006594866514205933, 0.02559957653284073, 0.25323712825775146, 0.007368003949522972, -0.04831916466355324, -0.297396183013916, 0.23316532373428345, 0.11065253615379333, 0.14751599729061127, -0.07689566910266876, 0.19912555813789368, -0.02367393672466278, -0.007538520731031895, 0.09129504859447479, 0.012415768578648567, 0.1328248530626297, -0.032558441162109375, 0.01061538141220808, 0.044437289237976074, 0.14421546459197998, 0.03232710063457489, -0.003274014685302973, 0.0709121972322464, 0.057880204170942307, -0.07023189961910248, -0.02751919999718666, 0.035797737538814545, 0.08815320581197739, 0.08897750079631805, -0.026561258360743523, -0.004639034159481525, 0.0739065557718277, -0.061771027743816376, -0.04257003217935562, 0.2088097184896469, -0.0331052765250206, -1.2494062029925282e-32, -0.041247785091400146, 0.019976109266281128, -0.012149753049015999, -0.03271108865737915, -0.1204807460308075, -0.043844074010849, 0.07458752393722534, 0.1398315578699112, -0.06555581092834473, -0.1739349067211151, -0.024805057793855667, -0.06338027119636536, -0.0678122341632843, 0.18224278092384338, -0.03148355334997177, -0.10743467509746552, 0.08720745146274567, -0.10422487556934357, 0.1768089085817337, -0.015599102713167667, 0.04414132237434387, 0.14451460540294647, -0.06207292526960373, 0.07135190069675446, 0.08310451358556747, -0.0658753290772438, 0.08833661675453186, 0.15667887032032013, -0.07135032117366791, -0.09602436423301697, 0.01905880495905876, -0.077908955514431, -0.010155782103538513, 0.12938369810581207, -0.04207243770360947, 0.08007292449474335, -0.03360426053404808, -0.10692451894283295, 0.001912455540150404, -0.06622494012117386, 0.040783002972602844, 0.007468994241207838, 0.060631632804870605, -0.0816037505865097, 0.03828366845846176, 0.06134340167045593, 0.12459474802017212, 0.11095521599054337, 0.04774847999215126, -0.04683049023151398, 0.04958045482635498, -0.04818187281489372, -0.1048920750617981, 0.11305390298366547, -0.2640484571456909, 0.09348836541175842, -0.0605706050992012, 0.041241638362407684, -0.06830234080553055, 0.06480175256729126, -0.026743071153759956, 0.16754862666130066, 0.05117351561784744, 0.0249861441552639, 0.019343087449669838, -0.041715383529663086, -0.0021442873403429985, -0.038132332265377045, 0.020701678469777107, -0.07659031450748444, 0.021647971123456955, -0.08606205880641937, -0.031088514253497124, 0.0015877869445830584, 0.06603159755468369, 0.10587140172719955, 0.05854766070842743, -0.13773877918720245, 0.057116396725177765, 0.050127096474170685, 0.004877803847193718, 0.10122910887002945, -0.034035492688417435, 0.03104282170534134, -0.1164393201470375, 0.1445479691028595, 0.04539754241704941, -0.07135553658008575, -0.10270169377326965, 0.03941688314080238, -0.11006805300712585, -0.10279868543148041, -0.15320123732089996, -0.008733262307941914, -0.002231425605714321, -1.0042063536275236e-07, 0.033256083726882935, -0.011459875851869583, 0.09671104699373245, 0.008341073989868164, 0.07960602641105652, -0.11873725056648254, 0.08254513144493103, -0.11447842419147491, 0.037332624197006226, 0.029665786772966385, 0.018739482387900352, -0.06557214260101318, -0.16919127106666565, -0.04506693780422211, -0.10952083766460419, -0.057905931025743484, -0.19999414682388306, 0.07880212366580963, -0.01674734614789486, -0.12227438390254974, 0.1035790964961052, 0.11760939657688141, 0.07159760594367981, -0.12579654157161713, 0.09867370128631592, -0.047857582569122314, -0.05205048620700836, -0.02297157421708107, -0.09707322716712952, 0.05540570616722107, -0.013407730497419834, -0.041564397513866425, -0.0039006653241813183, -0.04607445001602173, -0.0036044958978891373, -0.028481129556894302, -0.04441182315349579, 0.0766131728887558, 0.05385080724954605, 0.07280915230512619, 0.005059456452727318, -0.035501688718795776, 0.13474613428115845, -0.06951756030321121, -0.10768391937017441, -0.10620613396167755, -0.1566484570503235, -0.04170095920562744, 0.08340585231781006, -0.18618972599506378, 0.14361967146396637, -0.08979763090610504, 0.06342552602291107, 0.10393935441970825, 0.18201562762260437, -0.11302880942821503, -0.10705168545246124, -0.15262983739376068, -0.1651385873556137, -0.01553697045892477, 0.0685025006532669, -0.287075936794281, -0.00028869323432445526, 0.20873481035232544], "changes": {"1wk": 1.1551183551541415, "1mo": -13.201315535504266}}, {"text": "American Vanguard Announces Changes to Its Board Business Wire Fri, Dec 13, 2024, 12:45 AM 3 min read In This Article: AVD -1.62% Debra Edwards Retires; Carmen Tiu Joins with Extensive Risk and Regulatory Expertise NEWPORT BEACH, Calif., December 12, 2024 --( BUSINESS WIRE )--American Vanguard\u00ae Corporation (AVD), a leading manufacturer and marketer of innovative solutions for the agricultural industry in the areas of crop protection and nutrition, turf and ornamental management, and commercial pest control (the \"Company\"), announced that Debra Edwards is retiring from the board of directors and has therefore resigned. Ms. Edwards has been on the Board since 2011, having served as Chair of the Compensation Committee, as well as on the Risk and Finance Committees. Ms. Edwards commented, \"I have enjoyed my time on the Board of American Vanguard and I\u2019ve learned so much. I believe this is an exciting time for the Company and I look forward to monitoring its progress under newly appointed CEO, Dak Kaye.\" Scott D. Baskin, Lead Director of the Board, stated, \"We thank Debra for her distinguished service on our board over the past 13 years. Her knowledge of regulatory matters was invaluable, and we\u2019re grateful to have had someone of her caliber serving on our Compensation, Finance and Risk Committees. We will miss Debra \u2013 the person \u2013 as well as the knowledge and counsel she provided.\" To fill the vacancy left by Ms. Edwards\u2019 retirement, the Board appointed Carmen Tiu, effective December 11, 2024. Ms. Tiu will serve on the Risk and Finance Committees. She has extensive experience in the agriculture industry, having joined Dow AgroSciences in 1987 and served at its successor company Corteva AgroSciences in roles of increasing responsibility until earlier this year, primarily in regulatory strategy, food standards, risk, and government affairs. Mr. Baskin continued, \"We are excited to have Carmen join our board. Her deep technical knowledge, evidenced by 30+ scientific publications, 70+ scientific reports and hundreds of regulatory submissions, will bring further knowledge to Board discussions. Also, given her business background, we expect her to bring valuable expertise in the area of strategic business initiatives, such as transformation. We look forward to working with Carmen to help American Vanguard grow to new heights.\" About American Vanguard Corporation American Vanguard Corporation (AVD) is a diversified specialty and agriculture products company that develops and markets products for crop protection and management, turf and ornamentals management, and public and animal health. Over the past 20 years, through product and business acquisitions, the Company has expanded its operations into 21 countries and now has more than 1,000 product registrations in 56 nations, worldwide. To learn more about the Company, please reference www.american-vanguard.com . Story Continues The Company, from time to time, may discuss forward-looking information. Except for the historical information contained in this release, all forward-looking statements are estimates by the Company\u2019s management and are subject to various risks and uncertainties that may cause results to differ from management\u2019s current expectations. Such factors include weather conditions, changes in regulatory policy and other risks as detailed from time-to-time in the Company\u2019s SEC reports and filings. All forward-looking statements, if any, in this release represent the Company\u2019s judgment as of the date of this release. View source version on businesswire.com: https://www.businesswire.com/news/home/20241212899565/en/ Contacts Company Contact American Vanguard Corporation Anthony Young, Director of Investor Relations anthonyy@amvac.com (949) 221-6119 Investor Representative Alpha IR Group Robert Winters Robert.winters@alpha-ir.com (929) 266-6315 View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "AVD", "date": "2024-12-12T21:45:00+00:00", "sentiment": {"score": 0.11696235463023186, "confidence": 0.13283903896808624, "probabilities": {"positive": 0.13283903896808624, "negative": 0.015876684337854385, "neutral": 0.8512842655181885}}, "embedding": [-0.0761507973074913, -0.15868878364562988, -0.05518689379096031, -0.028557900339365005, 0.10937415063381195, 0.031169798225164413, 0.08287732303142548, 0.022823013365268707, 0.09595277160406113, 0.03584887459874153, -0.07961764931678772, 0.1553250253200531, -0.03931063041090965, -0.10052545368671417, -0.11605662107467651, 0.008655894547700882, 0.0037564276717603207, -0.007307169958949089, -0.12620705366134644, 0.12246669083833694, -0.006650070659816265, -0.029714079573750496, -0.07760186493396759, 0.032902248203754425, 0.0029877740889787674, -0.037276491522789, -0.10310386121273041, -0.015879565849900246, -0.19111822545528412, -0.10809531807899475, -0.05648796260356903, 0.04450734704732895, 0.04188017547130585, 0.02719547413289547, 0.05182256922125816, 0.010375168174505234, 0.02460106462240219, -0.05644172057509422, -0.00015635322779417038, -0.08859461545944214, -0.021907329559326172, -0.10157199203968048, -0.1233678013086319, 0.04426036775112152, -0.03353051841259003, -0.03753297030925751, -0.006093903444707394, -0.0023838444612920284, 0.06464958190917969, -0.055509552359580994, -0.020840484648942947, -0.05238489806652069, -0.005568930879235268, 0.007339272182434797, -0.009943755343556404, 0.13194066286087036, -0.021024342626333237, -0.05200333148241043, 0.017642401158809662, -0.05751277133822441, 0.10032153129577637, 0.03461392596364021, -0.0031219087541103363, 0.15440945327281952, 0.029651068150997162, -0.08618385344743729, -0.046705931425094604, -0.018313787877559662, -0.05633655935525894, -0.12059620022773743, 0.0054610250517725945, -0.0509893074631691, -0.12927386164665222, 0.13213683664798737, 0.08732627332210541, 0.20832732319831848, 0.19284138083457947, 0.12980225682258606, 0.17322003841400146, -0.14021754264831543, 0.04751700535416603, 0.1567520797252655, 0.10252532362937927, 0.05179264023900032, -0.06246177479624748, 0.0031125862151384354, 0.07059427350759506, -0.06864126026630402, 0.13621589541435242, -0.002678199438378215, 0.057994335889816284, -0.0742247998714447, 0.04311439022421837, -0.03716684877872467, -0.003667149692773819, -0.00795134250074625, -0.04485422372817993, -0.07239638268947601, -0.059882473200559616, 0.1301545947790146, -0.09980219602584839, 0.06891806423664093, -0.0877176895737648, -0.10052506625652313, -0.1525895893573761, -0.03226996585726738, 0.0535440668463707, -0.011590839363634586, 0.05547087639570236, 0.027516203001141548, -0.037541091442108154, 0.11834573745727539, -0.09129248559474945, 0.023983333259820938, -0.04008705914020538, 0.09069004654884338, -0.14842022955417633, -0.0008760301861912012, 0.14087042212486267, -0.08277277648448944, 0.09913390874862671, 0.15438902378082275, -0.07468121498823166, 0.08903306722640991, 0.018749132752418518, 0.04325879365205765, -0.006554365158081055, 6.175663079504374e-33, 0.02127676084637642, 0.035818420350551605, 0.008304234594106674, -0.013090366497635841, 0.013607827946543694, 0.08537118881940842, 0.0830032154917717, -0.02978750318288803, -0.08069232106208801, 0.05003393813967705, -0.1417224109172821, 0.03888378292322159, -0.0119318263605237, 0.0005035270005464554, 0.018944069743156433, -0.016458209604024887, 0.048013314604759216, 0.030903231352567673, 0.07863961160182953, -0.05332572013139725, 0.04852138087153435, -0.011363823898136616, -0.07646726816892624, 0.05182896554470062, 0.11136028170585632, -0.06153896450996399, -0.06861688196659088, 0.017494764178991318, -0.01577593944966793, 0.0786316767334938, -0.05344461277127266, -0.003714451100677252, 0.0329558365046978, 0.005501356907188892, -0.020262664183974266, -0.10740449279546738, -0.045682862401008606, -0.06165144592523575, 0.05191677063703537, -0.0030968384817242622, -0.018840737640857697, 0.158035010099411, 0.05207427963614464, 0.07885785400867462, -0.06521264463663101, -0.02477123960852623, 0.17507804930210114, 0.15331369638442993, 0.08174547553062439, -0.025589723140001297, -0.0356331430375576, -0.06041902303695679, 0.18626777827739716, -0.01728222519159317, 0.05294760316610336, 0.024970900267362595, 0.01943122409284115, -0.06602223962545395, -0.00996485911309719, -0.07454812526702881, 0.05894889682531357, 0.17769798636436462, -0.10673312842845917, -0.02143648825585842, -0.14399446547031403, 0.08233169466257095, 0.02396431565284729, -0.015236043371260166, 0.010590163990855217, 0.014611215330660343, -0.10806187987327576, -0.06669488549232483, 0.07668974995613098, 0.031945761293172836, -0.07392895221710205, -0.055181145668029785, 0.046014249324798584, 0.021551981568336487, 0.06212085112929344, -0.014658018946647644, -0.019625218585133553, 0.03461845591664314, -0.04645032808184624, -0.00996818020939827, 0.04163578525185585, -0.013872925192117691, 0.0892946720123291, -0.08116844296455383, -0.02590472251176834, 0.04380490630865097, 0.05827833712100983, 0.021574966609477997, 0.08051442354917526, 0.1086450070142746, -0.0018936247797682881, -6.906867585489869e-33, -0.15795022249221802, -0.06594774127006531, -0.052702996879816055, -0.050710394978523254, -0.011885875836014748, -0.09777623414993286, -0.00312203262001276, -0.07559036463499069, -0.019901901483535767, -0.3036022186279297, -0.02172563225030899, 0.0048750340938568115, -0.12065625190734863, 0.03960452228784561, -0.036751531064510345, 0.018224194645881653, -0.06647772341966629, -0.061093591153621674, 0.024374712258577347, -0.03380025923252106, -0.0025706570595502853, 0.19782614707946777, -0.02989252842962742, 0.012922879308462143, 0.06954375654459, -0.020965678617358208, 0.10565119981765747, 0.1931019127368927, -0.031659338623285294, -0.07967372238636017, 0.015322888270020485, -0.05858822539448738, -0.12333855777978897, 0.10999557375907898, -0.05814201384782791, 0.007349362596869469, 0.006778908893465996, -0.1650698333978653, 0.004063734784722328, -0.004220670089125633, 0.16407306492328644, -0.07168220728635788, 0.042467497289180756, 0.0103905089199543, 0.003382659750059247, 0.021845100447535515, 0.11924317479133606, -0.049548111855983734, 0.022661428898572922, 0.038953643292188644, -0.07519391179084778, -0.12533000111579895, -0.011928264051675797, 0.09168245643377304, -0.06358466297388077, 0.04588262736797333, 0.12484009563922882, 0.009858931414783001, 0.025138352066278458, -0.04949825629591942, 0.10907552391290665, 0.19770437479019165, 0.11037862300872803, 0.07072031497955322, 0.13535846769809723, 0.008961462415754795, 0.04052429646253586, -0.048443570733070374, -0.16438257694244385, -0.03622151538729668, -0.05169692635536194, -0.10482088476419449, -0.11301037669181824, -0.09438969939947128, 0.009644501842558384, 0.02994789183139801, -0.046253666281700134, -0.10683050006628036, -0.10014866292476654, 0.020919909700751305, -0.13880029320716858, 0.031416140496730804, -0.060697685927152634, 0.06485815346240997, 0.03005322255194187, 0.24747084081172943, 0.01685386709868908, -0.06655837595462799, 0.0326375775039196, 0.09061092138290405, -0.09653183817863464, -0.14489057660102844, 0.07554762810468674, 0.018141008913517, -0.04937176778912544, -1.001856588800365e-07, 0.10663353651762009, 0.07906775176525116, -0.04003652185201645, -0.061898358166217804, 0.14103925228118896, -0.10994776338338852, -0.011832493357360363, -0.05601918324828148, -0.03317516669631004, 0.08619100600481033, 0.019708935171365738, 0.10764747112989426, -0.010358694940805435, -0.07370561361312866, 0.07936234027147293, -0.039139650762081146, -0.03402763977646828, 0.13109354674816132, -0.14723503589630127, -0.0448526069521904, 0.03186964616179466, 0.0702565461397171, -0.10516728460788727, -0.029253367334604263, 0.01847989670932293, -0.076079361140728, 0.05911276862025261, 0.041801005601882935, 0.06530366092920303, 0.11067236214876175, -0.04408960044384003, 0.02165362983942032, 0.007708321325480938, -0.034255120903253555, -0.01374998688697815, -0.07036333531141281, -0.05831778794527054, 0.03333546221256256, -0.007463763002306223, 0.09660765528678894, -0.024111751466989517, 0.02745678648352623, 0.06639393419027328, 0.004063887521624565, -0.0033907582983374596, -0.04203977808356285, -0.06946621835231781, 0.028425924479961395, 0.06469950824975967, -0.09552757441997528, 0.047844503074884415, -0.09180059283971786, -0.002619353821501136, 0.10614762455224991, 0.0015040957368910313, -0.10961470007896423, -0.010654222220182419, -0.0819244384765625, -0.07989451289176941, -0.03387412056326866, -0.12125582247972488, -0.13213983178138733, 0.034794796258211136, 0.016870122402906418], "changes": {"1wk": -16.31878817128968, "1mo": -13.472486541112819}}, {"text": "American Vanguard Appoints Industry Veteran, Douglas A. (\"Dak\") Kaye, III as Chief Executive Officer Business Wire Thu, Dec 5, 2024, 5:00 PM 4 min read In This Article: AVD -1.62% Well-positioned to further accelerate transforming the global Company into an efficient, profitable, customer-centric organization NEWPORT BEACH, Calif., December 05, 2024 --( BUSINESS WIRE )--American Vanguard\u00ae Corporation (AVD), a leading manufacturer and marketer of innovative solutions for the ag industry in the areas of crop protection and nutrition, turf and ornamental management, and commercial pest control (the \"Company\"), today announced the appointment of Douglas A. (\"Dak\") Kaye, III as the new Chief Executive Officer following a unanimous vote from its Board of Directors (the \"Board\"), effective December 9, 2024. Mr. Kaye will be based at global headquarters beginning January 6, 2025. Mr. Kaye brings extensive experience to AVD and is expected to lead the Company into a new era of growth and innovation. He will succeed the Office of CEO (OCEO), which has been in place since July 15, 2024. Dak\u2019s global agricultural knowledge will be valuable in leading the Company. For the past 13 years, he has served in a variety of senior leadership roles at Albaugh, LLC, a top ten global crop protection company. He most recently held the role of President, North America, which is the largest region in the Company. Previously, he was Group Chief Commercial Officer, where he oversaw the commercial activities, which included North America, Europe, Brazil, Argentina, and Latin America regions. Mr. Kaye also served as President of the European region for seven years. Prior to his work at Albaugh, Dak was the CFO and a Director at a non-crop subsidiary of the crop protection company, Adama, and previously held the role of Co-CEO at an international automotive logistics organization. Mr. Kaye began his career at Arthur Andersen, LLP. He has a Masters of Accountancy and a Bachelor of Science in Business Administration, both from Auburn University. Mr. Kaye was recently elected to the Executive Board of the industry group CropLife America (CLA). \"We are excited to welcome Dak to American Vanguard,\" said Scott Baskin, Lead Director of the Board. \"His appointment is the result of a comprehensive search process that attracted many outstanding candidates. We are pleased that Dak has agreed to join American Vanguard to spearhead the next phase of the Company\u2019s business transformation,\" said Mr. Baskin. He continued, \"We believe that Dak is the right executive to drive the Company to achieve its transformation goal of generating an adjusted EBITDA margin of 15% and to strategically position the Company for future growth. I also want to thank the members of the OCEO for their leadership in the interim. While managing several significant changes simultaneously, they also jumpstarted the business transformation and the Company has greatly benefited from their hard work and dedication.\" Story Continues Mr. Kaye commented, \"I am grateful to be named American Vanguard\u2019s Chief Executive Officer at this important point in the Company\u2019s history. I have admired American Vanguard for many years. I view it as having strong relationships with customers by providing solutions that customers know and trust. I\u2019m confident we can accelerate the transformation underway, driving revenue growth and margin improvement. I look forward to leading the team to success!\" About American Vanguard Corporation American Vanguard Corporation (AVD) is a diversified specialty and agriculture products company that develops and markets products for crop protection and management, turf and ornamentals management, and public and animal health. Over the past 20 years, through product and business acquisitions, the Company has expanded its operations into 21 countries and now has more than 1,000 product registrations in 56 nations, worldwide. To learn more about the Company, please reference www.american-vanguard.com . The Company, from time to time, may discuss forward-looking information. Except for the historical information contained in this release, all forward-looking statements are estimates by the Company\u2019s management and are subject to various risks and uncertainties that may cause results to differ from management\u2019s current expectations. Such factors include weather conditions, changes in regulatory policy and other risks as detailed from time-to-time in the Company\u2019s SEC reports and filings. All forward-looking statements, if any, in this release represent the Company\u2019s judgment as of the date of this release. View source version on businesswire.com: https://www.businesswire.com/news/home/20241205450800/en/ Contacts Company Contact American Vanguard Corporation Anthony Young, Director of Investor Relations anthonyy@amvac.com (949) 221-6119 Investor Representative Alpha IR Group Robert Winters Robert.winters@alpha-ir.com (929) 266-6315 View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "AVD", "date": "2024-12-05T14:00:00+00:00", "sentiment": {"score": 0.11567751038819551, "confidence": 0.12604962289333344, "probabilities": {"positive": 0.12604962289333344, "negative": 0.01037211250513792, "neutral": 0.863578200340271}}, "embedding": [-0.06007236987352371, -0.08052845299243927, -0.03081575222313404, -0.07026287913322449, 0.14453046023845673, -0.01422117743641138, -0.019865598529577255, 0.0193676445633173, 0.0840803012251854, 0.05022621154785156, -0.00435205502435565, 0.04523609206080437, -0.11903990805149078, -0.05547383427619934, -0.13358823955059052, 0.01640508510172367, -0.011568796820938587, 0.061464693397283554, -0.166634202003479, -0.10834704339504242, 0.009691320359706879, 0.010541994124650955, -0.04980722814798355, -0.0323994942009449, -0.05705447494983673, -0.07575218379497528, -0.09811676293611526, -0.029572369530797005, -0.18625757098197937, -0.14503610134124756, 0.0495905876159668, 0.07611342519521713, 0.11832887679338455, 0.06981218606233597, 0.005308779887855053, 0.1299116015434265, 0.007759133819490671, -0.0732036828994751, -0.04271052032709122, -0.0939255952835083, 0.11898183822631836, -0.0872877910733223, -0.06393782794475555, -0.04041287302970886, -0.0539274588227272, 0.00857989490032196, -0.056589215993881226, 0.02485564909875393, 0.06253129988908768, 0.002367565408349037, -0.01624564826488495, -0.028410864993929863, -0.020392661914229393, -0.028826171532273293, -0.0025794552639126778, 0.09018070995807648, 0.04081834480166435, -0.05836869776248932, -0.0009628799743950367, -0.04859299957752228, -0.003820305224508047, -0.08680309355258942, 0.02749844267964363, 0.09733474254608154, 0.039289917796850204, -0.06770536303520203, -0.08634624630212784, -0.06519612669944763, -0.11526580154895782, -0.17781829833984375, 0.06598812341690063, -0.11629247665405273, -0.04260707646608353, 0.0916474238038063, 0.03531266748905182, 0.14331263303756714, 0.09651131182909012, 0.20149338245391846, 0.17295579612255096, -0.14374461770057678, 0.1777828484773636, 0.170623779296875, 0.03730881214141846, 0.03132142871618271, -0.1496017724275589, 0.005949588492512703, 0.0031070089899003506, -0.01638822630047798, 0.12323418259620667, 0.01967722922563553, 0.048068344593048096, -0.042861275374889374, 0.012948241084814072, 0.051001086831092834, -0.004661992192268372, 0.03960813209414482, 0.022746510803699493, -0.017579998821020126, -0.11895650625228882, 0.08621840178966522, -0.053095560520887375, 0.0022883042693138123, -0.07724461704492569, -0.114798404276371, -0.18164664506912231, -0.05499277263879776, 0.03170662745833397, -0.05497944727540016, 0.039819326251745224, 0.09645646810531616, -0.08133102208375931, 0.12680840492248535, -0.08555074781179428, -0.0792146772146225, -0.09026709198951721, -0.06713469326496124, -0.0768374353647232, -0.08673600852489471, 0.11210203170776367, -0.17300936579704285, 0.07878168672323227, 0.14397278428077698, -0.01331380009651184, 0.033082664012908936, 0.07898508012294769, 0.08651864528656006, 0.013447366654872894, 1.8433114259656453e-33, -0.05045367777347565, 0.022852595895528793, 0.05304267257452011, -0.026839394122362137, -0.03470117226243019, 0.0018070228397846222, 0.13467971980571747, -0.004974675830453634, 0.004288368858397007, -0.06980918347835541, -0.11517385393381119, -0.012396393343806267, -0.06228470057249069, 0.038128022104501724, -0.03165930509567261, -0.0043135033920407295, 0.08420391380786896, -0.004804269410669804, 0.002143105026334524, -0.01992747187614441, -0.018168967217206955, -0.07704561203718185, -0.08275533467531204, 0.14055806398391724, 0.17998471856117249, -0.06002742797136307, -0.0665995180606842, -0.08330366015434265, 0.015356283634901047, 0.10379420220851898, 0.06608398258686066, 0.06412534415721893, -0.04756243899464607, 0.06424544751644135, -0.034894973039627075, -0.031201686710119247, -0.16536059975624084, -0.042174093425273895, 0.015218592248857021, 0.04123895987868309, -0.026521937921643257, 0.12725281715393066, 0.02205265313386917, 0.0705476850271225, -0.0032281242311000824, -0.008112747222185135, 0.07489460706710815, 0.2080090343952179, 0.11348193883895874, 0.05122523009777069, -0.03017418086528778, -0.014781112782657146, 0.16230341792106628, -0.08062201738357544, 0.18987524509429932, 0.013160955160856247, -0.008959157392382622, -0.04554395377635956, -0.028048578649759293, -0.024478625506162643, 0.005668066442012787, 0.22286991775035858, -0.15527042746543884, 0.11472314596176147, -0.1099613681435585, -0.030502043664455414, 0.014487952925264835, 0.0118452413007617, 0.013572891242802143, 0.04224037751555443, 0.03334009647369385, -0.0711740106344223, 0.07322727143764496, 0.05392247065901756, -0.11389624327421188, -0.07318414747714996, 0.07835632562637329, 0.1284581571817398, -0.0036052772775292397, -0.023823007941246033, 0.00043249689042568207, 0.07038333266973495, 0.07129363715648651, -0.12309829145669937, -0.052835218608379364, 0.03392723947763443, 0.08380021899938583, 0.043313007801771164, 0.06780801713466644, 0.06093205139040947, 0.014576363377273083, 0.004594900645315647, 0.09430330246686935, 0.12900903820991516, 0.007721772883087397, -4.209088581227534e-33, -0.03221738338470459, -0.011622702702879906, -0.029011640697717667, -0.010406392626464367, 0.01643059402704239, -0.03410772979259491, 0.008468037471175194, -0.01053495705127716, -0.051315318793058395, -0.2663278579711914, 0.028469538316130638, 0.12046676129102707, -0.045944005250930786, 0.05228079855442047, 0.011583107523620129, 0.016875123605132103, 0.020438015460968018, 0.005884258542209864, 0.00317440927028656, -0.02386888861656189, 0.0519079715013504, 0.10275539010763168, -0.054493412375450134, 0.010022759437561035, -0.019166985526680946, -0.08627486228942871, 0.059350188821554184, 0.18229986727237701, -0.03723442554473877, -0.049294427037239075, 0.018977055326104164, 0.028400905430316925, -0.12684985995292664, 0.22548949718475342, -0.08703029900789261, -0.03162470459938049, -0.058915797621011734, -0.10813575237989426, 0.013365705497562885, 0.058153197169303894, 0.05747908353805542, -0.10448315739631653, -0.03151274472475052, -0.09116250276565552, -0.10324549674987793, 0.013591201975941658, 0.022290324792265892, 0.000581531785428524, -0.02325419895350933, -0.005665184929966927, -0.09088749438524246, 0.033817000687122345, -0.06847483664751053, 0.0657445639371872, -0.08849462121725082, 0.1703117936849594, 0.07749928534030914, 0.02740173041820526, -0.02755741961300373, -0.07891606539487839, 0.057131119072437286, 0.17469775676727295, 0.20461787283420563, 0.0040975576266646385, 0.08089937269687653, 0.018763307482004166, 0.06606650352478027, -0.006802975665777922, -0.08391094207763672, -0.01899070292711258, -0.05866425484418869, -0.01873968169093132, -0.06027453765273094, -0.1331951767206192, -0.05693946033716202, 0.05723128095269203, -0.0428934209048748, -0.09403915703296661, -0.13287627696990967, -0.07136976718902588, -0.1262577921152115, 0.046589504927396774, -0.016663961112499237, 0.10423710942268372, 0.008387568406760693, 0.21348363161087036, 0.006224406883120537, -0.13731172680854797, -0.029143087565898895, 0.14798477292060852, -0.14612992107868195, -0.09789302945137024, -0.0999172031879425, 0.08629924803972244, 0.04862254485487938, -1.0012512063894974e-07, 0.0677650198340416, 0.06560452282428741, -0.05648484453558922, -0.04785896837711334, 0.1524440348148346, -0.08170124888420105, -0.06542196124792099, -0.07059263437986374, 0.03225601464509964, 0.14794299006462097, -0.031104911118745804, 0.1008274182677269, -0.04709957540035248, -0.04332329332828522, 0.055826347321271896, -0.08681212365627289, -0.03765027970075607, 0.1522861123085022, -0.1121559888124466, -0.027679376304149628, 0.0023773720022290945, 0.12190265953540802, -0.07374300807714462, -0.03381619602441788, 0.019202474504709244, -0.041069358587265015, -0.0033608805388212204, -0.020066991448402405, 0.09848563373088837, 0.16447201371192932, -0.005012921057641506, 0.07313549518585205, -0.03978089615702629, -0.03754957765340805, -0.00669998861849308, -0.06546513736248016, -0.12522421777248383, -0.035765960812568665, 0.03049517050385475, 0.05133340507745743, -0.015019712969660759, 0.11314676702022552, 0.08032969385385513, -0.016776513308286667, -0.047609712928533554, -0.09313827008008957, -0.0877646654844284, -0.0005218973383307457, 0.028639448806643486, 0.033802930265665054, -0.020934153348207474, 0.03422660380601883, -0.009491020813584328, 0.05934635177254677, 0.06979157775640488, -0.10530409216880798, 0.047149330377578735, -0.2139827013015747, -0.029356664046645164, 0.023820914328098297, -0.13633620738983154, -0.2512753903865814, 0.06433116644620895, 0.12987776100635529], "changes": {"1wk": -8.417508336421937, "1mo": -21.88552488572164}}, {"text": "American Vanguard Corp (AVD) Q3 2024: Everything You Need to Know Ahead of Earnings GuruFocus News Fri, Nov 8, 2024, 3:05 PM 2 min read In This Article: AVD -1.62% American Vanguard Corp ( NYSE:AVD ) is set to release its Q3 2024 earnings on Nov 11, 2024. The consensus estimate for Q3 2024 revenue is $139.20 million, and the earnings are expected to come in at -$0.10 per share. The full year 2024's revenue is expected to be $571.95 million and the earnings are expected to be -$0.32 per share. More detailed estimate data can be found on the Forecast page . American Vanguard Corp ( NYSE:AVD ) Estimates Trends Warning! GuruFocus has detected 9 Warning Signs with AVD. Over the past 90 days, revenue estimates for American Vanguard Corp ( NYSE:AVD ) have seen a decline, moving from $596.75 million down to $571.95 million for the full year 2024, and from $628.95 million down to $598.75 million for 2025. Earnings estimates have also been adjusted, with expectations for the full year 2024 decreasing from $0.26 per share to -$0.32 per share, and for 2025 from $0.67 per share to $0.40 per share. American Vanguard Corp ( NYSE:AVD ) Reported History In the previous quarter of June 30, 2024, American Vanguard Corp's ( NYSE:AVD ) actual revenue was $128.21 million, which missed analysts' revenue expectations of $133.60 million by -4.04%. American Vanguard Corp's ( NYSE:AVD ) actual earnings were -$0.42 per share, which missed analysts' earnings expectations of -$0.045 per share by -833.33%. After releasing the results, American Vanguard Corp ( NYSE:AVD ) was up by 4.07% in one day. American Vanguard Corp (AVD) Q3 2024: Everything You Need to Know Ahead of Earnings American Vanguard Corp ( NYSE:AVD ) 12 Month Price Targets Based on the one-year price targets offered by 2 analysts, the average target price for American Vanguard Corp ( NYSE:AVD ) is $12.50 with a high estimate of $14 and a low estimate of $11. The average target implies an upside of 124.01% from the current price of $5.58. Based on GuruFocus estimates, the estimated GF Value for American Vanguard Corp ( NYSE:AVD ) in one year is $19.16, suggesting an upside of 243.37% from the current price of $5.58. Based on the consensus recommendation from 2 brokerage firms, American Vanguard Corp's ( NYSE:AVD ) average brokerage recommendation is currently 2.0, indicating an \"Outperform\" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell. American Vanguard Corp (AVD) Q3 2024: Everything You Need to Know Ahead of Earnings This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein. This article first appeared on GuruFocus . View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "AVD", "date": "2024-11-08T12:05:39+00:00", "sentiment": {"score": -0.9372998271137476, "confidence": 0.9601864218711853, "probabilities": {"positive": 0.022886594757437706, "negative": 0.9601864218711853, "neutral": 0.01692708022892475}}, "embedding": [0.022844646126031876, -0.13307523727416992, -0.10635040700435638, 0.04568013548851013, -0.012798354029655457, 0.03323070704936981, 0.00712522491812706, 0.04401680454611778, 0.257731169462204, 0.12872499227523804, -0.12891754508018494, 0.21841421723365784, -0.07038833945989609, -0.0679069459438324, -0.22952479124069214, -0.07452438026666641, -0.08296185731887817, -0.06350592523813248, -0.028883105143904686, 0.025558555498719215, -0.049517009407281876, -0.049884214997291565, 0.05658998340368271, -0.057582952082157135, 0.2570027709007263, -0.09003648906946182, -0.06826864928007126, -0.02889602817595005, -0.14078304171562195, -0.09822904318571091, -0.12262795865535736, -0.13666659593582153, 0.15661612153053284, -0.01126607321202755, -0.10520140826702118, -0.022356687113642693, 0.13774718344211578, 0.10172618925571442, 0.07177701592445374, -0.045982178300619125, -0.009375260211527348, -0.04553553834557533, -0.20909768342971802, -0.03281960263848305, -0.02291226200759411, -0.0028775548562407494, -0.21056140959262848, 0.1533345878124237, -0.0157790407538414, 0.11826035380363464, 0.006998835131525993, -0.0778806060552597, 0.09081103652715683, -0.01361910905689001, -0.09545263648033142, 0.12053528428077698, -0.10264437645673752, -0.08988333493471146, 0.1670340895652771, 0.0672113373875618, -0.06486885994672775, 0.0020743811037391424, 0.06595718860626221, 0.14941048622131348, 0.10722866654396057, -0.08490749448537827, 0.011661284603178501, 0.0061858841218054295, -0.1903829276561737, -0.009923318400979042, -0.032303307205438614, -0.052324868738651276, -0.14929163455963135, -0.060405001044273376, -0.06769083440303802, 0.15594476461410522, 0.06635935604572296, -0.012238345108926296, 0.029086913913488388, -0.07834947854280472, 0.09733877331018448, 0.02419109083712101, 0.00937731098383665, -0.06702013313770294, 0.008487059734761715, -0.01911437325179577, 0.2204347550868988, 0.08272035419940948, 0.13777436316013336, 0.01730995997786522, -0.0008325767703354359, -0.10672176629304886, -0.07965071499347687, -0.04417625814676285, 0.13575364649295807, -0.0019373223185539246, -0.021782977506518364, -0.11376172304153442, -0.07562951743602753, 0.05077589303255081, 0.07973254472017288, 0.10268466919660568, -0.07500778883695602, -0.11855942755937576, -0.09549976885318756, -0.0983782410621643, 0.09770557284355164, -0.00034322217106819153, 0.019736398011446, -0.013005796819925308, -0.12916827201843262, 0.14483219385147095, -0.1814994066953659, -0.11354469507932663, 0.006118804216384888, 0.031193599104881287, -0.08493369817733765, 0.0025376651901751757, 0.07409321516752243, -0.05493900179862976, 0.048624273389577866, 0.1663433015346527, 0.05429660156369209, 0.13376390933990479, -0.12507885694503784, 0.03950557857751846, -0.26492106914520264, 1.3757373155593687e-32, 0.02928147278726101, 0.02018796093761921, -0.024179190397262573, -0.14545270800590515, -0.13152767717838287, 0.09061646461486816, 0.14512069523334503, 0.01494126208126545, -0.11776652187108994, -0.11598614603281021, -0.1114276796579361, 0.056581124663352966, -0.0128742391243577, 0.09768769145011902, 0.030240166932344437, -0.06705692410469055, 0.060303520411252975, 0.07780250906944275, 0.11795803904533386, -0.13182884454727173, 0.09830863773822784, -0.0017513111233711243, -0.04792466387152672, 0.13175126910209656, 0.1561848223209381, -0.03951369971036911, -0.13893310725688934, 0.04263532534241676, -0.05824607238173485, 0.017363032326102257, -0.053352948278188705, 0.06116408482193947, -0.05950454622507095, -0.11665235459804535, 0.02621256373822689, -0.017977844923734665, -0.057360660284757614, 0.0845012366771698, 0.058526527136564255, -0.0190495103597641, 0.009031666442751884, 0.14062681794166565, -0.007926524616777897, -0.31269603967666626, -0.06114508956670761, 0.088234543800354, 0.05242307484149933, 0.08029477298259735, 0.059438273310661316, -0.06705547869205475, -0.1161518394947052, 0.11144589632749557, 0.0060063935816287994, -0.01876666210591793, 0.07260532677173615, 0.019185366109013557, -0.011022331193089485, -0.1339692622423172, -0.015413054265081882, 0.03909031301736832, 0.03878297284245491, 0.27873367071151733, -0.02290797419846058, -0.03728707879781723, -0.4020090103149414, 0.2536136507987976, 0.10189886391162872, 0.09180961549282074, -0.11373778432607651, 0.3229463994503021, -0.0027831653133034706, -0.04318452253937721, 0.14042024314403534, -0.03340979292988777, 0.12524649500846863, -0.11618290841579437, -0.02420130744576454, 0.026938511058688164, 0.15100915729999542, -0.045106686651706696, -0.03891235217452049, 0.10483063757419586, 0.12016408145427704, -0.061741508543491364, -0.0024316757917404175, -0.009311159141361713, 0.10575510561466217, 0.0816202312707901, -0.09138906002044678, 0.0043407403863966465, 0.05378793925046921, 0.008737752214074135, -0.019888240844011307, 0.2519577443599701, -0.06827452033758163, -1.5242356067204282e-32, -0.06489300727844238, 0.00794128980487585, 0.022111911326646805, -0.014456790871918201, -0.13957881927490234, -0.007697477471083403, 0.10801143199205399, 0.2476620078086853, -0.010762687772512436, -0.12126736342906952, 0.0076973470859229565, -0.03725050389766693, -0.1673576533794403, 0.15593042969703674, -0.02310667186975479, -0.06462610512971878, 0.06298226863145828, -0.2033558487892151, 0.21244394779205322, 0.0013769858051091433, 0.024639029055833817, 0.1817227154970169, 0.04467293620109558, 0.09275029599666595, 0.1575811207294464, -0.032201942056417465, 0.15733833611011505, 0.13046588003635406, -0.1813671886920929, -0.15323632955551147, 0.020003003999590874, -0.12042249739170074, -0.06228874623775482, 0.2070319950580597, -0.12187439203262329, 0.036766499280929565, 0.005919049959629774, -0.0808803141117096, 0.001822582446038723, -0.08220425248146057, 0.06973535567522049, 0.04663245379924774, 0.06931311637163162, -0.07580102235078812, 0.06647644191980362, 0.07715113461017609, 0.11509518325328827, 0.06037023290991783, 0.0167321115732193, -0.11089786887168884, -0.06791084259748459, -0.02072744630277157, -0.05164375156164169, 0.16795283555984497, -0.27129754424095154, 0.09587989002466202, -0.05618762969970703, 0.16287952661514282, -0.08783719688653946, 0.07700483500957489, 0.011958375573158264, 0.19794166088104248, 0.06311482936143875, 0.031504061073064804, 0.06306471675634384, -0.1188712865114212, 0.024770192801952362, 0.06843595206737518, -0.06392750144004822, -0.13342048227787018, 0.039991170167922974, -0.12762968242168427, 0.019157549366354942, -0.023743506520986557, 0.0865812748670578, 0.10002756863832474, 0.019015828147530556, -0.12402228266000748, 0.060852132737636566, 0.050254207104444504, 0.04300251603126526, 0.16047883033752441, -0.11598917841911316, 0.16423331201076508, -0.12864992022514343, 0.18517497181892395, 0.06089525297284126, -0.1005752831697464, -0.15079869329929352, 0.10419332981109619, -0.1194925531744957, -0.057361900806427, 0.005886591970920563, 0.04149694740772247, 0.01861727423965931, -1.0051235221908428e-07, 0.09036378562450409, 0.017925668507814407, 0.09557141363620758, -0.05895952507853508, 0.10723616182804108, -0.13446734845638275, 0.04446374252438545, -0.05606678128242493, -0.060355294495821, 0.0039543528109788895, 0.007682298310101032, -0.06578578054904938, -0.23042044043540955, 0.00600007176399231, -0.13057798147201538, -0.17526696622371674, -0.22360454499721527, 0.18094131350517273, -0.0019643628038465977, -0.14381960034370422, 0.11968071013689041, 0.19415080547332764, 0.052883632481098175, -0.17195484042167664, 0.08538694679737091, -0.025375835597515106, -0.03229020535945892, -0.10187789052724838, -0.04646825045347214, 0.06450023502111435, -0.05775667354464531, -0.02969568595290184, 0.009940419346094131, -0.14826086163520813, -0.03382475674152374, 0.026235289871692657, -0.06214689463376999, 0.02169300615787506, 0.0510762594640255, 0.1582450568675995, 0.0150495870038867, 0.018745625391602516, 0.17374321818351746, -0.09120097756385803, -0.09610316157341003, -0.07344309985637665, -0.2733202576637268, -0.11999242007732391, 0.08358348906040192, -0.19351163506507874, 0.20754331350326538, -0.10259472578763962, 0.12236185371875763, 0.09134361147880554, 0.09426244348287582, -0.18893003463745117, -0.11528593301773071, -0.17650862038135529, -0.20770680904388428, -0.09834504127502441, 0.13329817354679108, -0.3634071350097656, -0.045308541506528854, 0.298957884311676], "changes": {"1wk": 4.6793757680941725, "1mo": -0.17330592855690152}}]